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Research Institute of Public Health, School of Public Health and Clinical Nutrition, 
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work, he has believed in my work, tirelessly supported me and advised me on 
various matters. Even in some less exhilarating work-related matters he has always 
retained a twinkle in his eyes. The medical and especially cardiovascular expertise 
as well as supportive attitude of Matti J. Tikkanen is warmly acknowledged. The 
working atmosphere in his laboratory was enthusiastic and motivated. Tarja Nurmi 
has, as my co-author and supervisor, given an irreplaceable contribution to 
preparation of this thesis. Her ambitiousness and analytical expertise are something 
to really look up to, and I am truly thankful for all the effort. The collaboration with 
the University of Kuopio would not have been the same without my fourth 
supervisor, Sari Voutilainen. Along the way we have explored both the jungles of 
epidemiology and Southern Thailand. These experiences and memories are 
indelible! In addition to all the inspiring scientific contents and support during my 
co-operation with people from Kuopio, the stunning atmosphere both on duty and 
the fabulous parties at leisure can not be left unmentioned.  
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providing the herb material used in these studies. 
During this time, I was not always certain whether this project would ever reach its 
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ABSTRACT  
 
High dietary intake of fruits and vegetables has been linked to protection against 
chronic diseases, of which cardiovascular diseases (CVD) are the major cause of death 
in Finland. One of the hypotheses underlying the mechanism behind this effect is the 
antioxidant action of several dietary factors, including vitamins C and E, carotenoids 
and polyphenolic compounds. Polyphenols are consumed in large quantities in plant 
rich diets and observations on their antioxidant potency in vitro have made them a hot 
research topic during the past twenty years. The present study deals with the 
antioxidant activity of selected members of the plant family Lamiaceae – sage (Salvia 
officinalis L.), thyme (Thymus vulgaris L.), rosemary (Rosmarinus officinalis L.) and 
two oregano species (Origanum vulgare L., Origanum onites L.). Due to the 
abundance of various phenolic compounds in these herbs, they are considered as a 
potential source of health-beneficial natural components with usage as health-
promoting dietary supplements.  
The applicability of hydrodistillation, methanolic and ethanolic extraction, and 
pressurised hot-water extraction (PHWE) to extract phenolic antioxidants from sage 
was studied. Based on the 1,1-diphenyl-2-picrylhydrazyl radical (DPPH•) scavenging 
activity of the different extracts, PHWE was the most effective technique. The 
hydrodistillation method was chosen for the further production of study extracts due to 
sensory properties of the extracts suitable for human consumption. The technique was 
also easily applicable in a larger scale production. The in vitro antioxidant properties of 
water extracts from sage, rosemary, thyme and oregano (O. vulgare) were 
characterised using three radical scavenging assays, a reductive capacity assay and a 
human low-density lipoprotein (LDL) oxidation assay. The total phenolic content of 
these extracts was determined. Depending on the method used, the extracts showed 
varying degrees of antioxidant activity. The absorption and metabolism of oregano (O. 
onites) extract in humans was evaluated by analysing the urinary excretion of phenolic 
metabolites using liquid chromatographic methods. The excretion of phenolic 
metabolites in urine was markedly increased following a single ingestion of O. onites 
extract, and the pattern of urinary metabolites suggested effective metabolism to take 
place. The in vitro antioxidant activity of phenolic constituents and human metabolites 
of O. onites were studied in DPPH• and LDL oxidation assays. The phenolic acids 
from O. onites showed a range of antioxidant activity in the assays used, and some 
degree of activity was observed for many of the aglycone forms of their human 
metabolites. In a double-blinded, placebo-controlled clinical trial, the effects of 
oregano (O. vulgare) extract consumption on different biomarkers of antioxidant 
capacity and lipid peroxidation were studied in healthy men. No short- or long term 
effects on the antioxidant parameters followed were observed.    
This work revealed several aspects on the problematic nature of studies on 
antioxidants. Even though these extracts and their constituents seem promising 
antioxidant candidates in vitro and are at least to some extent available in the body, 
they lack effects on an array of lipid peroxidation and antioxidant capacity parameters 
in vivo. The findings suggest that their potential health-beneficial effects on humans are 
not mediated via direct antioxidant action. However, the epidemiologically observed 
association between the high intake of polyphenol rich fruits and vegetables and the 
decreased risk of CVD, as well as accumulating in vitro evidence on several 
bioactivities of polyphenols support the theory that polyphenols may have favourable 
effects on human health mediated via some other mechanisms.    
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TIIVISTELMÄ 
 
Epidemiologisten tutkimusten perusteella runsaasti kasviksia ja hedelmiä sisältävä 
ruokavalio vähentää riskiä sairastua sydän- ja verisuonisairauksiin. Yksi vahvimmista 
suojavaikutusta selittävistä teorioista pohjautuu ruokavalion hapettumista estävien eli 
antioksidatiivisten komponenttien, kuten C- ja E-vitamiinin, karotenoidien ja 
fenolisten yhdisteiden, toimintaan ihmiselimistössä. Tässä työssä tutkittiin 
Lamiaceae-heimon maustekasveja: salviaa (Salvia officinalis L.), timjamia (Thymus 
vulgaris L.), rosmariinia (Rosmarinus officinalis L.) ja kahta oreganolajiketta 
(Origanum vulgare L. ja Origanum onites L.)., jotka sisältävät runsaasti 
antioksidatiivisia fenolisia yhdisteitä. 
Työssä tutkittiin vesitislauksen, metanoli- ja etanoliuuton sekä paineistetun 
kuumavesiuuton käyttöä fenolisten antioksidanttien uuttamiseen salviasta. 
Uutteiden fenoliprofiili selvitettiin nestekromatografisesti ja niiden 
antioksidanttitehoa 1,1-difenyyli-2-pikryylihydratsyyliradikaalin (DPPH•) 
sieppaajina tutkittiin. Paineistettu kuumavesiuutto osoittautui menetelmistä 
tehokkaimmaksi. Osatöissä käytettävien uutteiden valmistamiseen valittiin 
vesitislaus, jolla valmistettujen uutteiden maku- ja hajuominaisuudet olivat 
käyttötarkoitukseen soveltuvat, ja joka oli helposti siirrettävissä suurempaan 
tuotantomittakaavaan. Salvian, rosmariinin, timjamin ja oreganon (O. vulgare) 
vesiuutteiden kokonaisfenolipitoisuus määritettiin, ja niiden antioksidantti-
ominaisuuksia koeputkimalleissa (in vitro) tutkittiin radikaalinsieppauskykyä, 
rautaionien pelkistämiskykyä ja low density lipoprotein (LDL) -kolesterolin 
hapettumisenestokykyä mittaavilla menetelmillä. Kaikki uutteet toimivat 
antioksidantteina käytetyissä koeputkimalleissa, mutta aktiivisuusjärjestys vaihteli 
menetelmittäin. Oreganon (O. onites) fenolisten happojen imeytymistä ja 
metaboliaa ihmiselimistössä arvioitiin tutkimalla uutteen nauttimisen jälkeen 
virtsaan erittyviä fenolisia metaboliitteja nestekromatografisesti. Metaboliittien 
määrä lisääntyi merkittävästi osoittaen, että ainakin osa uutteen fenolisista 
komponenteista imeytyi elimistöön. Yhdisteprofiilin perusteella uutteen fenoliset 
hapot metaboloituivat tehokkaasti. Saman uutteen fenolisten komponenttien ja 
niiden metaboliittien antioksidanttitehoa tutkittiin DPPH•- ja LDL-malleissa. 
Uutteen fenolisilla yhdisteillä sekä niiden metaboliittien aglykonimuodoilla 
havaittiin antioksidanttiaktiivisuutta; metaboliittien aktiivisuudet olivat lähtö-
aineitaan alhaisempia. Kaksoissokkoutetussa, lumekontrolloidussa kliinisessä 
kokeessa tutkittiin, onko oreganouutteella (O. vulgare) vaikutuksia elimistön 
antioksidanttikapasiteettiin tai rasvojen hapettumista kuvastaviin mittareihin 
terveillä miehillä. Lyhyt- tai pitkäaikaisia vaikutuksia ei havaittu. 
Tutkitut yrtit sisälsivät voimakkaita vesiliukoisia antioksidantteja, joista suurin osa 
oli fenolisia happoja. Ainakin osa oreganon fenolisista yhdisteistä imeytyi 
ihmiselimistöön ja metaboloitui tehokkaasti. Siitä huolimatta 45 koehenkilöllä 
tehdyssä syöttökokeessa ei havaittu antioksidanttivaikutuksia yleisesti käytetyillä, 
luotettavina pidetyillä mittareilla. Tulokset viittaavat siihen, että yrttien fenolisten 
yhdisteiden mahdolliset terveyshyödyt eivät välittyisi suoran antioksidantti-
vaikutuksen kautta. Runsaasti fenolisia yhdisteitä sisältävän, kasvis- ja 
hedelmäpainotteisen ruokavalion epidemiologisesti havittu yhteys alentuneeseen 
sydän- ja verisuonisairauksien riskiin sekä fenolisten yhdisteiden lukuisat 
bioaktiiviset mekanismit koeputkimalleissa viittaavat kuitenkin siihen, että 
terveyshyötyjä voisi välittyä jonkin muun mekanismin kautta. 
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ABBREVIATIONS 
 
AAPH 2,2'-Azobis(2-aminopropane) 
ABTS•+ 2,2'-Azinobis(3-ethylbenzothiazoline-6-sulphonic acid) anion 
 radical 
ALAT alanine aminotransferase 
CEAD coulometric electrode array detector 
CHD coronary heart disease 
CVD cardiovascular disease 
DPPH• 1,1-diphenyl-2-picrylhydrazyl radical 
EDTA ethylenediamine tetraacetic acid 
FC Folin-Ciocalteu 
GAE gallic acid equivalent 
GC-MS gas chromatography - mass spectrometry 
GI gastrointestinal 
γ-GT gamma-glutamyltransferase 
HDL high-density lipoprotein 
H2O2 hydrogen peroxide 
HP high phenolic 
HPLC high performance liquid chromatography 
IC50 inhibitory concentration 50% (for example, sample 
 conc. yielding 50% inhibition of DPPH• radical absorbance) 
LDL low-density lipoprotein 
LOD limit of detection 
LP low phenolic 
MCT monocarboxylic acid transfer 
NADPH nicotinamide adenine dinucleotide phosphate 
O2•- superoxide radical 
1O2 singlet oxygen 
OH· hydroxyl radical 
ORAC oxygen radical absorbance capacity 
ox-LDL oxidised form of LDL 
O. vulgare Origanum vulgare L. 
O. onites Origanum onites L. 
PBS phosphate-buffered saline 
PHWE pressurised hot-water extraction 
PI percentage inhibition 
PUFA polyunsaturated fatty acids 
RH fatty acid side chain of PUFA 
RO· alkoxyl radical 
ROO· peroxyl radical 
ROOH lipid hydroperoxide 
ROS reactive oxygen species 
R. officinalis Rosmarinus officinalis L. 
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SOD superoxide dismutase 
S. officinalis Salvia officinalis L. 
TBA thiobarbituric acid 
TEAC  Trolox® equivalent antioxidant capacity 
TRAP total radical-trapping antioxidant parameter 
T. vulgaris Thymus vulgaris L.  
VLDL very low-density lipoprotein 
US United States 
UV ultraviolet
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1. INTRODUCTION 
 
 
Oxygen is essential for the life of all higher eukaryotic organisms. However, even 
in the very fundamental metabolic reactions occurring in the cells, reactive forms of 
oxygen – so called free radicals- capable of damaging various to biomolecules such 
as proteins, deoxyribonucleic acid (DNA) or polyunsaturated fatty acids are formed 
(Davies, 1995). In addition to the normal production of free radicals in cell 
respiration and metabolism, excessive amounts of reactive oxygen species (ROS) 
can be formed and elevated oxidative stress caused due to a number of reasons such 
as smoking, inflammation, strong physical activity, ischemia or trauma. The lack of 
necessary protective nutrients or other antioxidant substances in diet or certain 
hereditary pathological conditions may also affect negatively the pro-oxidant – 
antioxidant balance in the body. If the amount of free radicals and oxidative stress 
exceeds the capacity of body’s antioxidant defence system, oxidative damage may 
result. The oxidation of lipids, carbohydrates, proteins and nucleic acids in the body 
has been linked e.g. with cardiovascular and neurological diseases, chronic 
inflammations and cancer (Kehrer, 1993; Gutteridge & Halliwell, 1994; Mariani et 
al, 2005; Valko et al, 2006; Halliwell, 2007). Even though the causality between 
oxidative stress and diseases in not clear (Gutteridge & Halliwell, 1994; Stocker & 
Keaney, 2004; Halliwell, 2007), free radicals are produced in greater amounts 
during several human diseases and types of tissue injury. Probably one of the most 
studied effects of oxidative stress on biomolecules is the oxidative modification of 
low-density lipoprotein (LDL) (Steinberg et al, 1989), role of which in the 
aetiology of atherosclerosis is well recognised. Today, antioxidants and their 
proposed beneficial effects on health have become an issue that interests, in 
addition to researchers of the field, conscious public worldwide.  
In order to maintain the essential antioxidant - pro-oxidant balance, human body is 
protected against oxidative stress by a complex antioxidant system. Antioxidants 
delay or prevent oxidative events (Halliwell, 1994a), and do not initiate further 
oxidative processes during their action (Bors et al, 1990; Galati et al, 2002). 
Protective mechanisms in the human body suppress the production of free radicals 
and other reactive species, scavenge these species, chelate transition metals needed 
to convert poorly reactive species into more reactive ones, repair damage to the 
target molecules or destroy badly damaged molecules and replace them with new 
ones (Gutteridge & Halliwell, 1994). The antioxidant defence system consists of a 
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network of enzymatic and nonenzymatic as well as endogenous and exogenous 
factors acting synergistically (Masella et al, 2005). Of the enzymatic factors, e.g. 
superoxide dismutase (SOD), catalase and glutathione peroxidase scavenge 
oxidising species, whereas proteins such as albumin, ceruloplasmin and transferrin 
participate in the antioxidant defence by binding transition metal ions iron and 
copper. Another type of enzymatic antioxidant action is to detoxify secondary 
products from reactions of ROS with macromolecules. Of the non-enzymatic 
antioxidants, α-tocopherol (often also called Vitamin E, even though Vitamin E 
comprises also other related substances) is of crucial importance in protection of 
lipophilic molecules (Gutteridge & Halliwell, 1994). Due to its effective radical 
scavenging capacity and molecular properties, it powerfully protects cell 
membranes from oxidation. Also lipophilic ubiquinol-Q10 and probably 
carotenoids have an antioxidative role in the body. 
In human serum and other extracellular fluids, hydrophilic antioxidants participate 
in protection against oxidative damage. Ascorbic acid, also called Vitamin C, acts 
as a free radical scavenger and probably recycles α-tocopherol back to its active 
form. Also uric acid/urate and bilirubin contribute to the antioxidant capacity of 
plasma. Vitamins C and E and carotenoids cannot be synthesized in human body, 
and must thus be derived from diet. Another class of dietary antioxidants is the 
diverse group of phenolic compounds, synthesised as secondary metabolites in 
plants. During the recent years, the epidemiological evidence on the health-
beneficial effects of diets rich in polyphenols (Bazzano et al, 2003; Hung et al, 
2004; Mink et al, 2007), has triggered wide scientific interest to polyphenol 
research. Even though findings are still not conclusive (Scalbert et al, 2005), they 
suggest high intake of flavonoids to be linked with decreased risk of CVD (Huxley 
& Neil, 2003; Arts & Hollman, 2005). As flavonoids are present in same dietary 
sources with other polyphenols, this finding might concern other classes of 
polyphenols as well. Oxidative damage is associated with and may be involved in 
the pathogenesis of major age-related diseases, due to which the mechanism behind 
the health-protective action of phenolic compounds has been proposed to be linked 
to their antioxidant action (Halliwell et al, 2005; Scalbert et al, 2005); a number of 
in vitro and animal studies on the effects of phenolic compounds favour the 
suggested antioxidant hypothesis. Based on this antioxidant theory, various 
polyphenol supplementation studies have been carried out in humans in order to 
provide proof for the suggested mechanism of action. A part of these studies have 
showed antioxidant effects on some parameters used, whereas others have reported 
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the lack of effects (Halliwell et al, 2005; Scalbert et al, 2005; Williamson & 
Manach, 2005). The most studied sources of polyphenols have been tea, red wine 
and cocoa (Williamson & Manach, 2005). In addition to the antioxidant hypothesis, 
also other pertinent mechanisms behind the health beneficial effects of action have 
been proposed. These include effects on the cardiovascular system as well as 
complex regulation of cell functions (Halliwell, 2007); however, this thesis is based 
on and focuses on the antioxidant hypothesis.  
Lamiaceae herbs, such as oregano and thyme, are part of a typical Mediterranean 
kitchen and diet. Especially oregano is consumed world-wide in pizza seasonings, 
and as pot herbs are today available in shops around the year, the regular 
consumption of fresh herbs in increasing also in Finland. In addition to their 
culinary properties, Lamiaceae herbs are a rich source of potentially health-
beneficial antioxidant polyphenols (Dragland et al, 2003). Even though their 
antioxidant properties in vitro are acknowledged, studies on their effects on humans 
are scarce. In the present work, selected Lamiaceae herbs with a common culinary 
usage were studied for their antioxidant properties in vitro and in humans. After 
assessing the in vitro antioxidant properties of sage, rosemary, thyme and two 
oregano species, the issues of bioavailability, metabolism and potential antioxidant 
action of oregano extracts in humans were studied using a variety of parameters 
reflecting antioxidant status as well as lipid peroxidation.  
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2. REVIEW OF THE LITERATURE 
 
2.1. Free radicals and lipid peroxidation 
 
2.1.1. What are free radicals? 
 
Free radicals are atomic or molecular species capable of independent existence that 
contain one or more unpaired electrons in their outer orbital (Gutteridge & 
Halliwell, 1994). This chemical character makes free radicals highly reactive. The 
reactivity varies from one free radical to another and is dependent on the 
environment they are presented in. As most free radicals are derived from 
molecular oxygen, they are usually referred to as ROS. Also reactive nitrogen and 
chlorine species of clinical significance exist, and some species without real radical 
nature i.e. unpaired electrons are usually included in the concept of free radicals 
due to their reactive nature, for example hydrogen peroxide (H2O2). Selected 
radical and nonradical oxidants with significance in vivo are presented in Table 1. 
The species considered to be the major contributors to oxidative stress in the human 
body (Huang et al, 2005) are marked with an asterisk (*). 
 
Table 1.  Selected radical and nonradical oxidants with significance in vivo. 
 
Name Chemical formula 
Superoxide radical* O2•- 
Hydroxyl radical* OH• 
Peroxynitrite* ONOO- 
Nitric oxide radical NO• 
Nitrogen dioxide radical NO2• 
Alkoxyl radical RO• 
Peroxyl radical* ROO• 
Hydrogen peroxide* H2O2 
Hypochlorous acid HOCl 
Singlet oxygen* 1O2 
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2.1.2. Sources of free radicals and other reactive species 
 
The metabolism of every aerobic organism produces ROS. Endogenously, they are 
mainly formed as by-products of electron transport chains of cell perspiration in 
mitochondria (Halliwell & Gutteridge, 1990a). Formation of ROS also occurs in 
different enzymatic reactions of nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidase and other oxidising enzymes in phagocytes, fibroblasts, smooth 
muscle cells and endothelial cells (Halliwell, 1994a; Stocker & Keaney, 2004). 
Phagocyte NADPH oxidase generating superoxide radicals is the most significant 
source of ROS production in the vascular system; xanthine oxidase, 
myeloperoxidase and nitric oxide synthases are examples of other enzymes that 
produce reactive oxygen and nitrogen species in human body. Autoxidation 
reactions of molecules such as catecholamines, tetrahydrofolates, quinones, thiols 
or flavins (Halliwell, 1994a) also produce free radicals capable of initiating 
oxidative events. Lipoxygenases and cyclooxygenases are involved in the synthesis 
of leukotrienes and prostaglandins, which have functions e.g. in mediating 
inflammation and regulating vascular tone and platelet aggregation; some of these 
enzymes are capable of oxidizing LDL (Stocker & Keaney 2004). Transition metals 
iron and copper catalyse oxidative reactions in the human body, and even if the 
amounts of free transition metal ions in body are low, iron stored in heme, 
hemoglobin or myoglobin has potential to initiate oxidative reactions (Halliwell, 
1994b; Rice-Evans, 1994). 
Exposure to ischemia, excessive exercise and infections are also conditions that can 
result in increased production of ROS. Exogenous exposure for ROS results e.g. 
from ionising (ultraviolet [UV], visible, thermal) radiation, excessive availability of 
transition metals or oxygen, certain drugs (e.g. paracetamol), toxic chemicals (e.g. 
carbon tetrachloride), cigarette smoke, excessive use of alcohol, air pollutants, 
herbicides (Gutteridge & Halliwell, 1994; Rice-Evans, 1994) or oxidised foods or 
beverages (Shahidi, 1997). The dietary burden of ROS results from peroxidised 
fatty acids or oxysterols that are absorbed in chylomicrons and finally incorporated 
into endogenous lipoproteins, or the oxidized dietary lipids may initiate oxidative 
cascades in the intestinal mucosa, resulting in oxidation of chylomicron lipids 
(Botham et al, 2005). The endogenous burden of ROS is, however, considered to 
be of far greater significance as compared to ROS from outside the body. The 
reactive species occurring most commonly in human is superoxide radical, O2•-. 
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The primary source of ROS, in the form of superoxide, is the NADPH oxidase 
complex that catalyses the one-electron reduction of molecular oxygen (equation 
1). The electrons required for production of O2-• are supplied by NADPH (eqn. 2): 
 
 O2 + e- → O2•-    (1) 
 
2 O2 + NADPH → 2 O2•- + NADP+ + H+  (2) 
 
O2•- itself has a rather low reactivity, but is capable of reacting further and 
dismutating to H2O2 (eqn. 3): 
 
 2O2•- + 2 H+ → H2O2 + O2   (3) 
 
Even though H2O2 itself is not highly reactive, it is diffusible and in presence of 
transition metals copper or iron in tissues or body fluids can give rise to formation 
of hydroxyl radicals (OH•), according to the so-called Fenton reaction (eqn. 4): 
 
Fe2+ + H2O2 + H+ → Fe3+ + OH• + H2O      (4) 
 
The formation of OH• is thus dependent on the availability of Fe2+ ions. It is also 
possible that products from this reaction react further (eqn. 5), resulting in 
formation of reactive ferryl ion: 
 
Fe3+ + OH• → Fe2+-O + H+   (5) 
 
Another reaction resulting in formation of hydroxyl radical takes place between 
superoxide and hydrogen peroxide in the presence of metal catalysts iron or copper 
(the Haber-Weiss –reaction, eqn. 6): 
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O2•- + H2O2 + H+ → O2 + OH• + H2O  (6) 
 
Oxidised transition metal ions (Fe3+, Cu2+) may also react with O2•- and be reduced 
(eqns. 7 and 8): 
 
Fe3+ + O2•- → Fe2+ + O2   (7) 
 
Cu2+ + O2•- → Cu+ + O2   (8) 
 
This capacity of O2•- to reduce iron and copper to forms that catalyse oxidative 
reactions is the main cause for its deleteriousness. OH• radical again is the most 
reactive oxygen species, and its capability to react with practically any biomolecule 
at high, diffusion-controlled reaction rate makes is extremely toxic (Halliwell, 
1994a). It potently oxidises lipids e.g. in cell membranes affecting their 
permeability characters and in lipoproteins, resulting in changes in the particle 
surface structure and thus altering its metabolism in the body. 
Radical action is often perceived only as oxidizing, i.e. a radical abstracts or accepts a 
single electron from a nonradical. Radicals can, however, also act as reducing agents 
thus donating a single electron to a nonradical (Stocker & Keaney, 2004). One of the 
main parameters governing the action of radicals is their reduction potential, which 
means the feasibility of one compound to chemically reduce another compound. 
Reduction potentials have been established for a number of biologically relevant 
compounds in order to predict the direction of reactions (Buettner, 1993). Difference 
in this thermodynamic parameter also offers an explanation for the recycling of α-
tocopheryl radical (α-TO•) back to its active form by ascorbate (eqn. 9): 
 
H+ + ascorbate- +   α-TO• → ascorbyl radical + α-TOH  (9) 
 
Originally, free radicals and other reactive species were believed to have their key 
role in the microbe defence. However, it is now known that they are also produced 
in the body in other contexts related to normal physiological processes via cell 
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signalling (Seifried et al, 2007). To fulfil the criteria for a cell signalling factor, 
ROS must be produced in cells as they are stimulated to do so i.e. the production is 
purposeful, have an action either in the cell where it is produced or a cell nearby, 
and to be removed to quench or reverse the signal (Hancock et al, 2001). The role 
of ROS depends on the species; OH• radicals are extremely detrimental to 
biomolecules whereas at least H2O2 and O2•- act as cell signalling factors. NADPH 
oxidase was first found in neutrofils producing superoxide as a response to 
microbial attack, but more recently it has also been shown to be present in cells 
with no role in host defence (Jones & Hancock, 2000), such as endothelial cells 
(Jones et al, 1996), mesangial cells (Radeke et al, 1991) and osteoclasts (Steinbeck 
et al, 1994). These cells produce levels of ROS remarkably lower as compared to 
phagocytic cells, and the location and distribution of these cells in the body is 
unexpected in terms of host defence, suggesting that the proposed role in signalling 
is justified. In resting cells, no NADPH activity is detected, and the activity is 
tightly controlled by several mechanisms (Jones & Hancock, 2000). This 
strengthens the hypothesis of ROS having a key role in signalling cascades 
(Hancock et al, 2001). 
 
2.1.3. Lipid peroxidation 
 
If the amount of ROS exceeds the capacity of the antioxidant defence system in the 
body, oxidative stress results and severe cellular damage may occur (Halliwell & 
Cross, 1994). In unfavourable circumstances, free radicals are capable of reacting 
with various biomolecules and inducing oxidative damage e.g. to proteins, nucleic 
acids, carbohydrates and lipids. In this thesis, the discussion is focused on oxidation 
of lipids and diseases with pathogenesis linked to oxidative processes. To clarify 
the terminology in the thesis, terms “oxidation” and “peroxidation” will be used 
synonymously. This is despite the fact that sometimes the term “peroxidation” is 
limited to use in oxidative processes induced by a peroxyl moiety (Kehrer & Smith, 
1994). Lipid peroxidation has been defined as the oxidation of polyunsaturated 
fatty acids (PUFA) by a radical-induced chain reaction (Frei, 1996) to form a lipid 
hydroperoxide (ROOH) which then reacts further. Oxidative chain reactions may 
occur in biological membranes or different lipoprotein particles circulating in 
blood. Of all lipoproteins, LDL is of the main interest in this study. 
 
 21
Chain reaction of lipid peroxidation 
 
As free radicals react with nonradicals, new radicals are generated. Hence, free 
radical reactions tend to proceed as chain reactions. The chain reaction –like 
process of lipid peroxidation is divided into three stages: initiation, propagation and 
termination. The reaction may be initiated by action of transition metals iron or 
copper, oxidative intracellular enzymes such as lipoxygenases or 
myeloperoxidases, or free radicals. In the following, the free radical –initiated 
cascade of lipid peroxidation is discussed more in detail. 
The oxidation reaction initiates, as free radicals or ROS abstract hydrogen atoms 
from the fatty acid side chain (RH) of PUFA and carbon-centered radicals are 
formed (eqn. 10) (Halliwell, 1995): 
 
OH• + RH → R• + H2O   (10) 
 
PUFA molecules have more than one double bond in their carbon chain, which 
facilitates the abstraction of hydrogen by reactive species. The rate of oxidation of 
fatty acids increases in relation to their degree of unsaturation. The process of 
oxidation proceeds to propagation phase, as carbon-centered radicals formed in the 
initiation phase react with oxygen as follows (eqn. 11):  
 
R• + O2 → ROO•   (11) 
 
The peroxyl radicals (ROO•) formed can attack adjacent fatty acid side chains, 
resulting in formation of ROOH (eqn. 12): 
 
ROO• + RH → ROOH + R•   (12) 
 
ROOH may be decomposed into lipid alkoxyl (RO•) and ROO• radicals in the 
presence of catalysing transition metals, inducing further oxidative damage. 
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The on-going chain reaction of oxidation is terminated when either PUFAs feasible 
to oxidation or oxygen supply are extinguished, or when the radicals formed are 
present in such excess that they start quenching each other (eqn. 13):   
 
ROO• + ROO• → non-radical products   (13) 
 
Diseases linked with oxidative stress 
 
In 1956, the process of ageing was for the first time suggested to be linked to the 
oxidation of biomolecules (Harman, 1956). Today, the evidence on the role of free 
radicals in ageing is strong (Rahman, 2007; Viña et al, 2007). Oxidative damage is 
connected with and probably has a role in the aetiology of several important age-
related diseases such as Alzheimer’s disease and Parkinson’s disease, cataract and 
cardiovascular diseases (Davies, 1995; Mariani et al, 2005), which has led to the 
assumption that antioxidants such as vitamins C and E, and based on their 
epidemiologically observed health-protective action, also foods rich in phenolic 
compounds, could have a role in protection against these diseases (Halliwell et al, 
2005; Scalbert et al, 2005).  In this thesis, further discussion is limited to oxidation 
of lipids, which plays a crucial role in the aetiology of cardiovascular diseases 
(CVD). The emphasis is put on its potential role in the pathogenesis, and in the 
other hand, prevention of CVD. 
 
Cardiovascular diseases and the role of oxidised LDL in atherosclerosis 
 
CVD are the major cause for morbidity and mortality in the developed countries. 
Even though the cardiovascular health programme carried out in Finland since late 
1970´s has succeeded in decreasing the general risk factor level of the population 
(Vartiainen et al, 2000), in 2006, CVD still accounted for more than 40% of all 
deaths in Finland (Statistics Finland, 2006). Within the variety of pathological 
conditions under the classification of CVD, coronary heart disease (CHD) and 
stroke were of the major significance, with 25% and 9% death causality, 
respectively. As the lifetime expectancy increases, the cost of CVD in the health 
care increases and reduces the available resources for other health priorities. The 
major and independent risk factors for CVD are male gender, ageing, smoking, 
hypertension, high serum total and LDL cholesterol, low serum high-density 
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lipoprotein cholesterol and diabetes (Grundy et al, 1999). Also genetic factors 
make a strong contribution to the risk of CVD. The pathological processes linked to 
the development of CVD begin already in the childhood (Kuller, 2006). Low 
physical activity, obesity, high intake of saturated fatty acids, cholesterol and salt, 
low intake of ω-3 and ω-6 PUFA and low intake of fiber and vegetables increase 
the risk of CVD (Dietary Guidelines Advisory Committee, 2005). The choices, by 
which an individual may beneficially modify the risk of CVD, are linked to 
healthier life-style and dietary habits. 
According to the widely accepted theory of “oxidative modification hypothesis”, 
the oxidation of PUFAs in LDL particles has an important role in the initiation and 
progression of atherosclerosis (Steinberg et al, 1989; Witztum, 1994; Berliner & 
Heinecke, 1996; Stocker & Keaney, 2004). The level of LDL, or more specifically, 
the level of apolipoprotein B (apoB), and the number of LDL particles are 
important determinants of the development of atherosclerosis (Kuller, 2001). 
Human atherosclerosis is an arterial disease, which slowly progresses 
predominantly in the medium size arteries such as the coronary, carotid and 
vertebral arteries, but also in the aorta and arteries supplying the lower extremities 
(Clarke & Armitage, 2002). The main site for LDL oxidation has been assumed to 
be in the arterial intima, and only to a small extent in plasma (Witztum, 1994). In 
the early stage of LDL oxidation, in vitro evidence shows minimally oxidized LDL 
to induce production of monocyte chemotactic protein, resulting in recruitment of 
inflammatory cells and increased production of ROS (Stocker & Keaney 2004). 
The oxidation is initiated by free radicals, and catalysed by transition metal ions 
(Pinchuk & Lichtenberg, 2002). At the early stage of oxidation, the surface 
structure of LDL particle remains intact; as the oxidation proceeds, apoB-100 on 
the LDL surface is modified. Most of LDL oxidation occurs following the entry of 
LDL particles into the arterial intima when these particles lose the protection of 
water-soluble antioxidants present in plasma. Oxidized LDL is recognized by 
scavenger receptors of macrophages residing in the arterial intima and avidly 
internalized into these cells. Unlike LDL receptors, scavenger receptors are not 
regulated by any negative feedback mechanism, and the macrophages continue to 
internalize oxidized LDL until they become lipid-laden foam cells, and finally burst 
resulting in accumulation of cholesterol in the artery wall. This initiates the 
formation of the atherosclerotic plaque. The plaques consisting of cholesterol, 
calcium, proteins and other components gradually obstruct the arteries. The 
fragility of these plaques may lead to ruptures and, consequently, to formation of a 
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blood clot obstructing the artery. As the thrombus propagates, it, combined with 
vasoconstriction of the artery, leads to total blockage of the blood flow resulting in 
damage of the heart or brain i.e., heart attack or stroke. The theory of oxidised LDL 
(ox-LDL) being of crucial significance in the pathogenesis of CVD is supported by 
the findings showing that ox-LDL is present in atherosclerotic lesions both in 
animals and humans (Stocker& Keaney, 2004). Also other mechanisms related to 
oxidative stress may contribute to the progression of atherosclerosis: for example, 
superoxide radicals inactivate nitrogen oxide and thus enhance proatherogenic 
mechanisms such as impaired vasodilatation, platelet aggregation and leukocyte 
adherence to endothelium (Landmesser & Harrison, 2001). 
 
2.2. ANTIOXIDANTS 
 
2.2.1. What are antioxidants? 
 
From a biological point of view, antioxidants have been defined as substances that 
in concentrations lower compared to the substrate susceptible to oxidation are 
capable of delaying or inhibiting oxidative processes (Halliwell, 1994a). In this 
definition, “substrate” refers to any oxidisable molecule in vivo: lipids, proteins, 
carbohydrates and DNA. As antioxidants react to protect biological targets from 
oxidation, they are themselves oxidised. The stability of an oxidised antioxidant 
molecule is essential, as to prevent oxidation from progressing, oxidised 
antioxidants must retain low reactivity towards biomolecules (Bors et al, 1990). 
The use and meaning of term antioxidant depends on the scientific discipline: for 
example, in food sciences, antioxidants comprise both substances used to 
preventing fats in foods from becoming rancid as well as dietary antioxidants. In 
this thesis, a biological perspective on antioxidants is adopted. 
 
2.2.2. Mechanisms of antioxidant defence in humans 
 
Cells in the human body are throughout prone to attacks of ROS and resulting 
oxidative reactions. If the pro-oxidant-antioxidant balance of the human body is 
disturbed due to excessive oxidative stress or inadequate antioxidant defense, lipids, 
carbohydrates, proteins and nucleic acids are exposed to oxidative damage. Balance 
between oxidative stress and protection by body’s antioxidant defence system is a 
vital condition for the health of human tissues and organisms. Human body uses all of 
 25
the following antioxidant mechanisms: scavenging oxidizing species, either by 
enzymes or by direct chemical reactions; minimizing the formation of oxygen-
derived and other reactive species, binding metal ions needed to convert poorly 
reactive species such as H2O2 or O2•- into highly reactive ones; repairing damage to 
the target and destroying badly damaged target molecules and replacing them with 
new ones (Gutteridge & Halliwell, 1994). 
Radical scavenging enzymes SOD, catalase, glutathione peroxidase, thioredoxin 
reductase and peroxiredoxin provide the first-line defence against oxidizing species 
(Masella et al, 2005). The antioxidant function of SOD found both intra- and 
extracellularly is based on its ability to catalyse the dismutation of O2•- into oxygen 
and H2O2. As O2•- is one of the major pro-oxidants in human body, SOD capable of 
reacting rapidly with ROS accounts for antioxidant function of great significance in 
vivo. Catalase functions via decomposing excessive H2O2 to oxygen and water by 
an extremely rapid turnover rate. Glutathione peroxidase, found practically in all 
human tissues, comprises a family of enzymes, which reduce ROOH to their 
corresponding alcohols and H2O2 to water. Glutathione peroxidase, as well as 
glutathione S-transferase, aldo-keto reductase and aldehyde dehydrogenase, also 
detoxify secondary products from reactions of ROS with macromolecules, whereas 
proteins albumin, ceruloplasmin and transferrin chelate transition metal ions. 
Imbalance of micronutrients such as copper or selenium in human body may lead to 
dysfunction of enzymatic antioxidant defense, as these substances have a role in 
antioxidant defense as antioxidant enzyme cofactors. Also substances that inhibit 
oxidative enzymes, for example cyclooxygenase, act as antioxidants in the body. 
Even though the harmful effects of a number of radicals are counteracted by 
enzymatic antioxidants, no enzymatic action is known to scavenge ROO•, OH•, 1O2 
or ONOO-, reactive species which are, together with O2•- and H2O2, among the six 
major factors causing oxidative damage in human body (Huang et al, 2005). For 
this reason, effective radical scavenging by nonenzymatic antioxidants is 
fundamental to complement the defense system.    
All human cell membranes consist of phospholipid bilayers with large number of 
PUFA molecules prone to oxidative attacks, damage of which leads to detrimental 
alterations in membrane fluidity and function. Thus, antioxidant protection of the 
lipid phase is of crucial significance in human body. The most important of 
lipophilic antioxidants in human body is vitamin E. It comprises multiple isomers 
of four tocopherols and four tocotrienols, of which α-tocopherol is of major 
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importance (Halliwell et al, 2007). Molecules of all isomers contain a chromanol 
ring with hydroxyl group, and a hydrophobic side chain, which allows the 
molecules to fuse into biological membranes. The hydroxyl group attached to 
chromanol ring is capable of donating a hydrogen atom or an electron and thus 
scavenging radicals. Vitamin E protects biomembranes from oxidation by an 
effective chain-breaking antioxidant action, maintaining normal permeability 
characters and cellular composition (Gutteridge & Halliwell, 1994; Morrissey & 
Sheehy, 1999). During the radical-scavenging action, α-tocopherol is converted to a 
radical, i.e. consumed. Interestingly, even though the antioxidant action and the 
epidemiological inverse association of vitamin E and CVD are well recognised, 
recent clinical trials have failed to show detectable effects of lipid peroxidation 
parameters or mortality (Clarke & Armitage, 2002). 
Another compound capable of protecting the membranes of human body is 
ubiquinol, also called coenzyme Q-10. Ubiquinol has its key role in the 
mitochondrial electron transport chain, but may also act either by direct chain-
breaking radical scavenging or by regenerating α-tocopherol radicals back to 
functional α-tocopherol (Gutteridge & Halliwell, 1994). Also lipophilic 
carotenoids, especially β-carotene, have been suggested to participate in the 
antioxidant protection of human body. Carotenoids are antioxidants in vitro, and 
high plasma β-carotene concentrations have been associated with a decreased risk 
of CVD; however, large scale clinical trials have failed to show antioxidant effects 
in human and in fact, even pro-oxidant effects at higher dosages have been reported 
(The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group, 1994; 
Voutilainen et al, 2006). 
Of the hydrophilic non-enzymatic antioxidants, vitamin C, or ascorbic acid, and 
glutathione are most probably the two with major significance. Ascorbic acid has 
several metabolic roles in the human body, but is also widely thought to be an 
important antioxidant in vivo, both directly and concurrently with vitamin E. It can 
reduce radicals from a variety of sources, and also appears to participate in 
recycling vitamin E radicals (see eqn. 9). It is, similarly to vitamin E, readily 
absorbed from the human gastrointestinal (GI) tract, and human body has evolved 
mechanisms for taking up ascorbate and transporting it into cells (Halliwell, 1999). 
Glutathione is a tripeptide (glutamyl-cysteinyl-glycine) with a reactive thiol group, 
which provides an abundant target for radical attacks. Reaction with radicals 
oxidizes glutathione, but the reduced form is regenerated in a redox cycle involving 
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glutathione reductase and the electron acceptor NADPH. Glutathione also is 
capable of regenerating α-tocopherol radicals back to their active form. Also uric 
acid/urate and bilirubin act as extracellular scavengers of different reactive species 
in the body fluids; uric acid may also chelate transition metal ions whereas bilirubin 
has the potential to be involved in recycling of α-tocopherol radical (Stocker & 
Keaney, 2004). 
Of the abovementioned factors of human antioxidant defence, vitamins E and C or 
carotenoids cannot be synthesized in the human body and must thus be obtained 
from dietary sources. In dietary plants and plant-derived foods and beverages, these 
components as well as a wide variety of other phytochemicals - minerals, dietary 
fibre, phytosterols and phenolic compounds - are administered to humans. They 
have been suggested to exert health-beneficial properties and to be associated with 
decreased risk of various diseases (Meltzer & Malterud, 1997). At the moment, the 
antioxidant hypothesis suggests also dietary polyphenols to be involved in the 
network of biologically relevant antioxidants. In chapter 2.3., these phytochemicals 
and their significance to humans is discussed in more detail. 
 
2.2.3. Assessment of antioxidant capacity and lipid peroxidation 
 
The interest focused on antioxidants and their action has resulted in the 
development of an array of methods to assess antioxidant capacity and lipid 
peroxidation. Of the methods available today, none alone provides enough 
information to assess or characterize the whole process of oxidation, and can thus 
be referred to as the ultimate method of choice. Differences in methods and their 
modifications used, lack of adequate chemical characterization of samples tested, 
lack of usage of robust standards as well as differences in the interpretation of 
results obtained have lead to a situation, in which comparison and pooling of results 
from different published studies is very difficult, if not unfeasible. Stating that a 
certain sample tested is a good antioxidant is meaningless without separating out 
the methods used (Gutteridge & Halliwell, 1994). Only providing of the specific 
conditions such as temperature, possible coreactants, reaction media and reference 
points enables discussing on the antioxidant activity of a sample or a substance 
(Huang et al, 2005). For the abovementioned reasons, consensus on the necessity of 
standardizing the use of antioxidant methodologies is rising. In the following, 
selected methods for assessing antioxidant capacity and lipid peroxidation are 
briefly described with limitation to methods considered as potential reference 
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methods or otherwise relevant in the context of this study. The activities of 
antioxidant enzymes such as blood/plasma glutathione peroxidase, SOD or catalase 
have also been used to evaluate the effect of dietary antioxidants or antioxidant 
supplementation; however, this approach is excluded from this methodological 
discussion. 
The antioxidant capacity of foods, botanicals, dietary supplements as well as 
human samples such as plasma or urine has been evaluated using different methods 
reflecting their free radical scavenging or reducing capacity. Based on evaluation of 
data presented in antioxidant-related congresses and journal articles, some of these 
methods have recently been proposed to be considered for standardization, or as 
reference methods, when assessing antioxidant capacity. In their expert review, 
Prior et al (2005) state that a standardized method for testing antioxidant capacity 
should fulfil the following requirements: measuring chemistry that actually occurs 
in potential applications, employing a biologically relevant source of radicals, 
simplicity, defined endpoint and known chemical mechanism, reasonable 
instrumentation, good reproducibility, adaptable for testing antioxidants of varying 
partition coefficient as well as adaptable for high-throughput approach analyses. 
Also, the methods suggested to be used as standards in measuring antioxidant 
activity need to have been used for a sufficient time and in a number of 
laboratories, establishing their strengths and weaknesses. Consequently, Prior et al 
suggest the following assays as methods of choice for standardizing assessment of 
antioxidant capacity: the oxygen radical absorbance capacity (ORAC) assay, the 
total radical trapping capacity parameter (TRAP) assay, the Folin-Ciocalteu (FC) 
method and possibly the Trolox equivalent antioxidant capacity (TEAC) assay. Of 
these assays, Huang et al (2005) suggest in their review FC method as the method 
of choice for the determination of reductive capacity, and ORAC assay as the 
standard method for determining the peroxyl radical scavenging capacity of a 
sample.  
ORAC and TRAP assays measure the inhibition of peroxyl radical mediated 
oxidation thus reflecting the chain breaking action of an antioxidant (AH) by 
hydrogen atom transfer mechanism (eqn. 14): 
 
ROO• + AH → ROOH + A•   (14) 
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The FC method measures the reductive capability of a sample by single electron 
transfer mechanism (eqn. 15): 
 
M(n) + e (from AH)  M(n-1) + AH•-  (15) 
 
TEAC assay reflects the radical scavenging capacity of a sample against 2,2'-
azinobis(3-ethylbenzothiazoline-6-sulphonic acid) anion radical (ABTS•+) by single 
electron transfer mechanism. In this assay, ABTS is oxidized resulting in formation 
of ABTS•+ radical, and the radical scavenging action of a sample is determined 
based on decrease in radical absorbance at 734nm. The TEAC value for the sample 
is calculated from a Trolox® calibration curve. A number of modifications of this 
method have been established, presented also on names other than TEAC, but they 
all are based on detecting the scavenging capacity against ABTS•+ radical. 
In addition to TRAP, FC and TEAC methods described above, DPPH• radical 
scavenging assay, Fe3+-ethylenediamine tetraacetic acid (EDTA)/H2O2/ascorbate-
catalysed deoxyribose oxidative degradation assay for determining the OH• 
scavenging activity, Fe3+ to Fe2+ reduction capacity assay by thiocyanate method, 
copper-induced LDL oxidation assay, copper-induced serum oxidation assay, LDL 
baseline conjugated dienes assay and determination of plasma F2-isoprostane 
formation were employed in this study. 
The DPPH• radical scavenging assay reflects the capacity of a sample to reduce this 
nitrogen centered radical mainly by single electron transfer mechanism; the 
hydrogen atom transfer mechanism has supposedly a marginal role (Huang et al, 
2005). In the deoxyribose oxidative degradation assay, OH• radicals are produced in 
aqueous reaction solution containing FeCl3 and H2O2 by Fenton chemistry (see 
chapter 2.1.2). Ascorbate and EDTA are included in the reaction mixture for their 
metal chelating properties. To assess the degree of deoxyribose degradation, the 
oxidative degradation product malonaldehyde is condensated with thiobarbituric 
acid, and quantified by spectrophotometrical measurements at 532 nm (Halliwell et 
al, 1987). Antioxidants capable of OH• radical scavenging act by hydrogen atom 
transfer mechanism. Fe3+ to Fe2+ reduction capacity assay (thiocyanate method) is 
based on determination of capacity of a sample to reduce Fe3+ to Fe2+ by single 
electron transfer mechanism. 
The in vitro (also referred to as ex vivo) oxidation of LDL is most often initiated by 
copper ions (Esterbauer et al, 1989), but also iron or azo compounds producing 
hydroxyl radicals at a constant rate (Noguchi et al, 1993), or oxidative enzymes 
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may be used (Noguchi & Niki, 1998). The oxidation resistance of unsaturated fatty 
acids in human LDL particles either without addition of antioxidant or with 
addition of the antioxidant sample is determined by continuously measuring the 
formation of conjugated dienes at 234 nm, and most often, the antioxidant activity 
is determined as the lag-phase prior to the maximal rate of oxidation. Antioxidants 
in this assay may act by inhibiting the onset of oxidation and/or decreasing the 
maximal rate of oxidation (Pinchuk & Lichtenberg, 2002). The determination of 
human serum resistance against copper-induced oxidation reflects the in vivo 
antioxidant capacity of the whole serum, whereas the so-called LDL baseline 
conjugated diene method has been developed to indicate the state of non-induced 
LDL oxidation in vivo (Ahotupa & Vasankari, 1999). 
F2-isoprostanes, products of nonenzymatic oxidation of arachidonic acid, are 
chemically stable and are thus possible to determine in plasma or urine, in which 
they are finally excreted. Increased concentrations of these substances have been 
reported in association with risk factors for CVD: smoking, diabetes and 
hyperlipidemia (Patrono & FitzGerald, 1997). Most often they are analysed from 
human samples using gas chromatographic – mass spectrometric methods. Also F3- 
and F4-isoprostanes, arising from peroxidation of eicosapentaenoic acid residues 
and docosahexaenoic acid residues, respectively, can be measured to determine the 
peroxidation of different PUFA residues in vivo (Halliwell, 1999). 
 
2.3. PHENOLIC COMPOUNDS 
 
2.3.1. What are phenolic compounds or polyphenols? 
 
Phenolic compounds are plant secondary metabolites produced either from 
phenylalanine via the acetate pathway or from its precursor shikimic acid via the 
shikimate pathway (Harborne, 1989). Being widely distributed and synthesized 
throughout the plant kingdom, with exception of fungi and algae, phenolic 
compounds are one of the most numerous classes of substances. By 1993, they 
were known to comprise more than 8000 substances (Harborne, 1993). Even 
though the structural variety within this class of compounds is substantial, all 
phenolic compounds are characterised by the presence of a phenolic ring, i.e. a 
benzene ring substituted with a hydroxyl group. Although the literal reading of 
“polyphenolic” refers to a structure with more than one hydroxyl group, terms 
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“phenolic compounds” and “polyphenols” are most often used in parallel. For 
verbal flexibility, this practice also applies to this thesis. 
Phenolic compounds occur mainly in conjugated forms in plants, as conjugation of 
hydroxyl groups with sugars (most often glucose) increases the solubility of 
polyphenols and makes them suitable to be stored in plant vacuoles (Bravo, 1998). 
Polyphenols have several important physiological functions in plants: they are 
essential for the regulation of growth and participate in the reproduction by 
attracting pollinating insects, and also protect plants against UV radiation, harmful 
insects and infections (Harborne, 1989; Korkina, 2007). They can be divided into 
different subclasses as a function of the number of phenol rings and structural elements 
binding these rings to each other (Manach et al, 2004). Based on this classification, 
distinctions are made between the phenolic acids, flavonoids, stilbenes and lignans; the 
diversity is further expanded as polyphenols are associated with various carbohydrates 
and organic acids and with each other. The class of flavonoids, for example, may be 
further divided into 6 subclasses depending on the type of heterocycle in their molecular 
structure: flavonols, flavones, isoflavonoids, flavanones, flavanols (i.e. catechins) and 
anthocyanidins (Manach et al, 2004). Of the polyphenol subclasses, phenolic acids and 
flavonoids are the most common and have often been described to be the most 
important as regarding the intake and potential effects in humans (Bravo, 1998). As 
may be deduced by the large number of phenolic compounds and the discrepancy 
between the different subclasses, their chemical and biological properties vary greatly. 
Phenolic acids, the class of phenolic compounds with the main weight in this study, can 
be divided to those with a simple hydroxybenzoic acid structure (such as protocatechuic 
acid) and to those with hydroxycinnamic acid structure (such as caffeic adic or 
rosmarinic acid) (Manach et al, 2004) So far, the group of phenolic acids has been 
studied far less as compared to flavonoids. Especially hydroxybenzoic acids have not 
been considered to be of greater nutritional interest, as they are present in edible plants 
only in low amounts, with exception of some red fruits, berries, onions and cereals 
(Manach et al, 2004; Mattila et al, 2005; Mattila et al, 2006). Hydroxycinnamic acids 
are commonly found in plants, and representatives of this class, such as caffeic acid, 
chlorogenic acid and ferulic acid, have been studied more. This study and literature 
review focuses on phenolic acids with some discussion on flavonoids related to our 
work. As an example of different phenolic structures, the molecules of main interest in 
this study are shown in Figure 1. In addition to phenolic acids and their metabolite 
aglycones, flavonoids luteolin (a representative of flavone subclass) and eriodictyol (a 
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representative of flavanone subclass) identified from O. onites extract are presented as 
structural examples of the flavonoid class. 
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Figure 1. Phenolic compounds with the main interest in this study. 
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2.3.2. Phenolic compounds as antioxidants 
 
The antioxidant potential of phenolic compounds has been shown in a number of in 
vitro studies. They are capable of direct chain-breaking antioxidant action by 
radical scavenging: in addition to being capable of scavenging of several non-
physiological radicals such as DPPH• and ABTS•+ (Kosar et al, 2003; Payet et al, 
2005; Cai et al, 2006), they are capable of scavenging a variety of reactive species 
such as superoxide, hydroxyl and peroxyl radicals and hypochlorous acid with 
significance in vivo (Halliwell et al, 2005). They can also suppress the formation of 
reactive oxygen species by chelating transition metal ions capable of catalyzing 
oxidative reactions (Morel et al, 1994; Mira et al, 2002). It has been stated that 
without these catalysts the harmful event caused by free radicals would be much 
less (Halliwell et al, 1992); this points out the significance of antioxidants with 
transition metal chelating or reducing action. Furthermore, polyphenols inhibit 
oxidative enzymes such as lipoxygenases and cyclooxygenases involved in 
inflammatory reactions (Laughton et al, 1991; Sadik et al, 2003; O'Leary et al, 
2004), thus suppressing the formation of free radicals. These mechanisms are 
classified as preventive antioxidant action. For example, the inhibitory or delaying 
action of polyphenols against oxidation in the LDL oxidation assay, seen as 
increased lag-time and/or decreased rate of LDL oxidation in the propagation phase 
relates to several mechanisms of antioxidant action. In addition to radical 
scavenging, metal chelation, reductive action and enhancing of hydroperoxide 
decomposition (Pinchuk & Lichtenberg, 2002), polyphenols have been suggested to 
inhibit the oxidation of LDL by binding certain proteins containing catalytic metal 
sites (Teissedre et al, 1996; Satué-Gracia et al, 1997). 
In addition to having potential for independent antioxidant action, polyphenols 
have been suggested to spare essential antioxidants. Selected flavonoids have been 
shown to be able to reduce the ascorbyl radical, i.e. to protect vitamin C (Bors et al, 
1995). The regeneration of α-tocopherol through reduction of the α-tocopherol 
radical has been suggested as one mode of action for polyphenols, for example 
caffeic acid (Rice-Evans et al, 1995, 1996; Nardini et al, 1995; Natella et al, 1999). 
In study of Nardini et al (1995), caffeic acid was also shown to protect β-carotene 
against oxidation. Also synergism between different antioxidants has been 
suggested; for example, in copper-induced oxidation of human LDL in vitro, 
combining phenolic compounds with each other resulted in synergistic protection 
against LDL lipid and protein oxidation (Yeomans et al, 2005; Cirico & Omaye, 
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2006), although also opposite result showing antagonism between phenolic 
compounds in the LDL assay have been reported (Meyer et al, 1998). 
The direct antioxidant capacity of phenolic compounds is essentially due to the ease 
with which a hydrogen atom from an aromatic hydroxyl group can be donated to a 
free radical (equation 14 in 2.2.3.), and the stabilization on the phenoxyl radical by 
delocalization of unpaired electrons around the aromatic ring (Rice-Evans et al, 
1996; Frankel & Meyer, 2000). The lower the bond-dissociation energy in the 
aromatic hydroxyl group, the faster will the reaction with a radical be (Wright et al, 
2001). In addition to hydrogen donation, also single electron transfer mechanism 
(equation 15 in 2.2.3.) with ionisation potential as the crucial determinant for 
electron transfer capability is involved in the antioxidant action of polyphenols 
(Wright et al, 2001). However, hydrogen donation mechanism is considered to be 
more important for the radical scavenging action of most polyphenols (Wright et al, 
2001). The radical scavenging capacity depends on the chemical structure of 
phenolic compound in question, affecting also its capacity to protect different 
biomolecules from oxidation. Even though details depend on the radical used, the 
following general structure-activity rules seem to apply for phenolic acids: 1) 
radical scavenging action requires a free hydroxyl group, 2) effective radical 
scavenging requires the presence of  an aromatic ortho-dihydroxyl moiety, 3) 
radical scavenging activity is increased as the number of free hydroxyl groups 
increases, and 4) electron-donating substituent(s) such as methoxy group(s) next to 
aromatic hydroxyl group(s) enhance the hydrogen donation ability (Rice-Evans et 
al, 1996; Natella et al, 1999; Cai et al, 2006: Siquet et al, 2006). Of these 
requirements, the presence of an ortho-dihydroxyl moiety also applies to capability 
of transition metal chelation (Nardini et al, 1995; Natella et al, 1999). As a second 
hydroxyl group is introduced in the ortho-position in the phenol structure, the 
antioxidant effectiveness is increased due to the stabilisation of the phenoxyl 
radical through an intramolecular hydrogen bond (Rice-Evans et al, 1996). In 
radical scavenging, the effects of the alkyl spacer between the carboxylic acid 
group and the aromatic ring seem more complex. A double bond in the alkyl chain 
has been suggested to enhance the radical scavenging activity (Cai et al, 2006), 
whereas some other studies have reported the opposite (Silva et al, 2000; Siquet et 
al, 2006). In the work of Siquet et al (2006), the effect of alkyl chain length was 
also studied using DPPH• and ABTS•+ radicals, and the radical scavenging activity 
of benzoic acid derivatives was increased by addition of an alkyl chain. This is in 
accordance with earlier work of Rice-Evans et al (1996). An explanation for this 
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phenomenon is that the alkyl side chain stabilises the phenoxyl radical formed 
(Brand-Williams et al, 1995; Siquet et al, 2006). 
In the case of flavonoids, the structural criteria for maximal radical scavenging are: 
1) the ortho-dihydroxy structure in the B-ring, 2) the 2,3-double bond in 
conjugation with the 4-oxo function in the C-ring, and 3) the 3- and 5-hydroxy 
groups with the 4-oxo-function in the unsaturated C-ring. (Bors et al, 1990; Rice-
Evans et al, 1996; Heijnen et al, 2002; Cai et al, 2006). If all these criteria are 
fulfilled, as in case of flavonols, a conjugated double bond system allowing 
electron delocalization in the molecule is formed, stabilising the radical and 
enhancing the antioxidant activity (Bors et al, 1990; Rice-Evans et al, 1996). In 
heterogeneous substrates, such as in foods or biological systems, the antioxidant 
action and structure-activity relationship become more complex, as the physico-
chemical properties of the antioxidant, like lipophilicity, solubility and partition 
between lipid and aqueous phase become significant (Frankel, 1995). The structure-
activity relationship is not only significantly affected by the test system used and 
the biological targets to be protected, but also by the modes of inducing oxidation 
and by the method used to determine oxidation. Also, most often a variety of 
antioxidant mechanisms are involved (Frankel & Meyer, 2000). 
 
2.3.3. Phenolic compounds and cardiovascular health 
 
Epidemiological evidence 
 
During the past fifteen years, tens of epidemiological studies on the role of fruits, 
vegetables and polyphenols, especially flavonoids, have been published. The 
starting point for the renewed interest in phenolic compounds was the Zutphen 
Elderly Study, in which a relation between the high intake of flavonoids and the 
reduced risk of CVD was first established (Hertog et al, 1993a). Since then, several 
studies have detected an association between the consumption of polyphenol-rich 
foods or different polyphenols and the risk of cardiovascular diseases (Mennen et 
al, 2004; Andersen et al, 2006), myocardial infarction (Hirvonen et al, 2001; 
Geleijnse et al, 2002; Tavani et al, 2006), stroke (Keli et al,1996; Knekt et al, 
2002) or CHD and/or cardiovascular disease mortality (Hertog et al, 1995; Knekt et 
al, 1996; Yochum et al, 1999; Arts et al, 2001a; Mink et al, 2007). Also studies 
with no association have been reported (e.g. Arts et al, 2001b; Rimm et al 1996; 
Sesso et al, 2003; Lin et al, 2007), and for example in a study by Hertog et al 
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(1997), the intake of flavonols was associated with increased risk of all-cause 
mortality. Explanations for this discrepancy have been suggested to be found in 
possible confounding lifestyle factors. Some meta-analyses on cohort and case-
control studies have also been carried out. In a meta-analysis of Peters et al 2001, 
including data from altogether 17 studies, moderate tea consumption decreased the 
risk of myocardial infarction by 11%. As Huxley & Neil (2003) made a meta-
analysis of 7 studies, high intake of flavonols reduces the risk of CHD by 20%. So 
far, epidemiological studies assessing the cardiovascular protective effects of 
polyphenols have focused on flavonoids, especially flavonols and catechins, and to 
a lesser extent, catechin polymers i.e. procyanidins. The association between the 
intake of phenolic acids, compounds of the main interest in the context of this 
thesis, and cardiovascular diseases has not been studied. The source of phenolic 
acids most studied in epidemiological work is coffee. However, results from 
epidemiological studies on coffee have remained controversial. In a meta-analysis 
by Myers & Basinski (1992), including data from 11 studies, no association 
between coffee consumption and risk of CHD was found. A J-shaped association 
between coffee consumption and CVD has been reported (Panagiotakos et al, 2003; 
Happonen et al, 2004). Consumption of whole grain cereals has also been shown to 
protect against CVD (Flight & Clifton, 2006); however, the role of phenolic acids 
found in whole grains in the protection is currently not known.  
Even though the data from epidemiological studies is not fully consistent, they 
seem to indicate that persons who consume more fruits and vegetables or other rich 
sources of polyphenols often have lower prevalence of important risk factors for 
CVD as well as decreased risk of developing CVD incidents such as CHD 
(Bazzano et al, 2003; Hung et al, 2004; Arts & Hollman, 2005; Manach et al, 
2005). The biological mechanisms behind the protective effects of fruits, vegetables 
and other polyphenol rich foods are not entirely clear and are likely to be multiple. 
Many nutrients and phytochemicals in fruits and vegetables, including fiber, 
potassium, and folate, could be independently or jointly responsible for the 
apparent reduction in CVD risk. The low dietary glycemic load and energy density 
of fruits and vegetables may also play a significant role. However, support for the 
hypothesised antioxidant action and protective effects of phenolic compounds 
against cardiovascular diseases has been found in supplementation studies both in 
animals and in humans. 
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Supplementation studies on phenolic compounds 
 
Supplements rich in flavonoids have been shown to have antioxidant effects in 
different animal models. For example, reduced progression of atherosclerosis in 
apolipoprotein E-deficient mice has been reported following consumption of red 
wine, quercetin or catechin, an effect associated with reduced susceptibility of LDL to 
oxidation (Hayek et al, 1997). Administration of green or black tea decreased the 
susceptibility of LDL to oxidation in rabbits (Tijburg et al, 1997). In study of 
Yamakoshi et al (1999), proanthocyanidin-rich extract from grape seeds decreased 
the levels of lipid peroxidation products in plasma and inhibited the development of 
aortic atherosclerosis in cholesterol-fed rabbits. Red wine polyphenol 
supplementation showed to offer protection against early atherosclerosis in hamsters, 
the mechanism suggested to have been linked e.g. with increased plasma antioxidant 
capacity and elevated levels of antioxidant enzymes (Auger et al, 2005). Dried grape 
powder inhibited development of atherosclerosis in apolipoprotein E deficient mice 
and reduced macrophage atherogenicity against LDL (Fuhrman et al, 2005). The 
effect could have been at least partly mediated by increased serum antioxidant 
capacity. In majority of animal studies reporting preventive effects against 
atherosclerosis or other pathological changes linked to cardiovascular diseases, levels 
of oxidative stress in animals were decreased. The polyphenol sources most often 
used have been tea, cocoa and red wine. 
Similarly to animal studies, also human polyphenol interventions have focused on 
the effects of catechins, flavonols and procyanidins from tea, red wine and cocoa 
(Williamson & Manach, 2005). Also studies on other phenolic compounds, for 
example isoflavonoids have been carried out: in study of Tikkanen et al (1998), 
administration of soy-derived isoflavonoids decreased LDL oxidation susceptibility 
in humans. For the most studied classes of polyphenols, sufficient data from 
supplementation studies exists to evaluate the type and extent of their antioxidant 
effects in humans (Williamson & Manach, 2005). Catechins from green tea, black 
tea or tea polyphenol concentrates have been found e.g. to increase plasma 
antioxidant capacity (Sung et al, 2000; Young et al, 2002; Reddy et al, 2005), 
decrease levels of lipid peroxidation products in plasma (Nakagawa et al, 1999; 
Freese et al, 1999; Reddy et al, 2005), increase plasma vitamin C concentrations 
(Gomikawa & Ishikawa, 2002) and increase the resistance of LDL to oxidation 
(Ishikawa et al, 1997). Supplementation with red wine, red wine dealcoholised to 
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remove the confounding effects of ethanol, or red wine polyphenols (procyanidins, 
anthocyanidins and quercetin) have resulted in similar findings: increased 
antioxidant capacity (Carbonneau et al, 1997; Serafini et al, 2000), lowered levels 
of lipid oxidation products in plasma and increased resistance of LDL against 
oxidation (Fuhrman et al, 1995; Nigdikar et al, 1998; Tsang et al, 2005). In 
addition, decreased F2-isoprostane formation has been reported (Caccetta et al, 
2001; Pignatelli et al, 2006). Cocoa polyphenols, mainly procyanidins and 
catechins, have also exerted some antioxidant effects in humans (see review of 
Williamson & Manach, 2005); however, the proof of their effects on plasma 
antioxidant capacity or lipid peroxidation does not seem as strong as for tea and red 
wine polyphenols. Of the flavonol class, quercetin is the most studied 
representative. In intervention studies using supplements rich in quercetin, some 
effects suggesting cardiovascular protective antioxidant action in vivo have been 
shown (McAnlis et al, 1999; Chopra et al, 2000); however, the evidence is limited 
and many studies have failed to show antioxidant effects (Williamson & Manach, 
2005). For polyphenols in aforementioned classes of compounds, also vasodilatory 
effects and improvement of endothelial function have been described, most 
probably due to increased production of nitric oxide (Duffy & Vita, 2003; Stoclet et 
al, 2004; Vita, 2005; Williamson & Manach, 2005). Furthermore, e.g. decreased 
blood pressure, inhibition of platelet aggregation, angiogenesis and cell migration 
and proliferation in the vascular system have been attributed to these compounds 
(Stoclet et al, 2004; Williamson & Manach, 2005). The epidemiologically observed 
cardiovascular protection by high polyphenol diets could be partly explained by 
these effects. Although beneficial changes in the aforementioned parameters have 
been observed, also lack of effects has been reported (Halliwell et al, 2005; 
Williamson & Manach, 2005). Taken all these observations together, it seems that 
polyphenols of these classes tend to transiently increase the plasma antioxidant 
capacity, the effect on lipid peroxidation being less announced. 
Results from human intervention studies using phenolic acids as supplement are 
remarkably lower in number, and the show of their antioxidant effects in vivo is not 
as strong. Studies on coffee, containing e.g. high amounts of chlorogenic acid, have 
however suggested that phenolic acids might exert antioxidant action in humans. 
Coffee was shown to increase plasma antioxidant capacity by Natella et al (2002). 
In the recent work of the same group (Natella et al, 2007), coffee drinking was 
shown to increase the incorporation of conjugated forms of caffeic acid, p-coumaric 
acid and ferulic acid into LDL particles, and the oxidation resistance of LDL was 
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increased. Some support for the potential in vivo antioxidant properties of phenolic 
acids can be found in animal studies. Caffeic acid supplementation increased 
plasma antioxidant capacity in rats, and although caffeic acid was not incorporated 
into LDL particles, the resistance of LDL against oxidation was enhanced (Nardini 
et al, 1999). Furthermore, caffeic acid increased levels of Vitamin E in plasma and 
LDL particles.  In a study of Balasubashini et al (2004), ferulic acid 
supplementation of rats with induced diabetes resulted in decreased lipid 
peroxidation and increase in antioxidant enzymes. In a recently published study of 
Luceri et al (2007), supplementation of rabbits with p-coumaric acid resulted in 
significantly increased plasma antioxidant capacity and decreased platelet 
aggregation. Even though this finding was made in an animal model, it is still 
interesting, as p-coumaric acid is one of the most commonly occurring phenolic 
acids. In another recent work, supplementation of high-cholesterol fed rats with p-
hydroxybenzoic acid or p-hydroxyphenylpropionic acid, metabolites of citrus 
flavonoid naringenin, decreased levels of plasma and hepatic lipid peroxidation 
products and increased the levels of antioxidant enzymes. Also lipid-lowering 
effects e.g. in plasma total cholesterol and triglycerides were observed (Jeon et al, 
2007). Yang et al (2006) demonstrated in high-cholesterol fed rats that plasma 
antioxidant capacity was correlated with atherosclerotic index. 
It is important to notice that study setting has an ultimate key role in clinical 
studies, and cautiousness is needed in the interpretation of study results. For 
example, elevated levels of F2-isoprostanes after fasting have been reported 
(Richelle et al, 1999; Lee et al, 2004). E.g. Lotito & Frei (2004) have shown that 
the increase observed in parameters reflecting plasma antioxidant status following 
consumption of apples was due to increase in urate, endogenous plasma 
antioxidant, caused by fructose present in apples, and not due to antioxidant activity 
of apple polyphenols in vivo. 
To conclude, although the data supporting the antioxidant significance of 
polyphenols in vivo remains inconsistent, the evidence on the antioxidant potential 
of phenolic compounds in vitro, the epidemiological observations on the disease-
preventing properties of diets rich in polyphenols, and the recognised role of 
oxidative damage in the aetiology of various diseases suggest the antioxidant 
hypothesis behind their health benefits to be reasonable. As mentioned above in the 
case of flavonoids, phenolic compounds have also several other potential 
mechanisms of action which may, independently or more probably concurrently be 
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involved in the observed protection against CVD. In addition to effects on the 
cardiovascular system, several effects may be mediated via complex regulation of 
cell signalling systems (Halliwell, 2007). 
 
2.3.4. Dietary sources and intake of phenolic compounds 
 
Due to the ubiquitous production of phenolic compounds in plants, practically all 
plant-derived foods and beverages act as sources of dietary phenolics making them 
important constituents of the nonenergetic part on human diet. The most commonly 
mentioned rich sources of dietary polyphenols probably are fruits and vegetables, 
berries, tea, red wine, cocoa and coffee. In addition to these, e.g. herbs, cereals, 
nuts, beer and cider provide a source for polyphenol intake. The content of phenolic 
compounds in different foods or beverages varies by several orders of magnitude 
(Bravo, 1998). Depending on the amounts and types of polyphenols present, foods 
exert different in vitro antioxidant capacities, most often determined as TEAC 
values. In Table 2., some dietary sources of different types of polyphenols are 
presented together with determined TEAC values for these products. 
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Table 2. Some dietary sources of different types of polyphenols and their TEAC 
values. PP = polyphenol. 
 
Type of PP Examples  Product PP content TEAC 
Hydroxybenzoic Gallic, vanillic, Blackberry 80-270 3.990  
acids protocatechuic acid Raspberry 60-100 2.334  
 Strawberry 20-90 2.15  
 Rye grain 9 1 1.164 2  
Hydroxycinnamic Caffeic, chlorogenic, Blueberry 2000-2200 2.154  
acids ferulic, p-coumaric acid Oregano, dried 1440 3 40.299  
 Kiwi 600-1000 1.325  
 Wheat bran 434 1 1.577 4  
 Rye grain 116 1 1.164 2  
 Apple 50-600 0.224-0.536  
 Potato 100-190 0.168-0.417  
 Coffee 350-1750 1.249  
Flavonols Quercetin, myricetin, Yellow onion 350-1200 0.236  
 kaempferol Broccoli 40-100 0.248  
 Blueberry 30-160 2.154  
 Apple 20-40 0.224-0.536  
Flavones Hesperetin, eriodictyol Parsley 240-1850 7.430  
Flavanones Luteolin, apigenin Orange juice 215-685 0.566  
Anthocyanins Cyanidin, malvidin, Black currant 1300-4000 0.644-1.313 5  
 delphinidin Blueberry 250-5000 2.154  
 Black grape 300-7500 0.316  
 Red wine 200-350 2.135  
Monomeric Catechin, epicatechin Chocolate 460-610 2.567-4.188  
flavanols Green tea 100-800 0.441-0.969 5  
 Black tea 60-500 0.388-0.770 5  
 Apple 20-120 0.224-0.536  
 Red wine 80-300 2.135  
If not otherwise indexed, polyphenol contents (mg/100g or mg/100mL) refer to Manach et al, 
2004 (see for references). 
If not otherwise indexed, TEAC values (mmol/100g) refer to Halvorsen et al, 2006 (see for 
references). 
1 Mattila et al, 2005   
2 Pellegrini et al, 2006   
3 Kosar et al, 2003   
4 Martínez-Tomé et al, 2004   
5 Schlesier et al, 2002      
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When examining these TEAC values, it needs to be considered that the values for 
all the berry and vegetable samples were determined from raw samples, and they 
are usually largely increased by cooking procedures (Halvorsen et al, 2006). 
Furthermore, TEAC values between studies cannot be fully compared with each 
other. For example, in paper of Pellegrini et al, the TEAC value for fresh O. 
vulgare leaves was 3.065 mmol/100g, and in the paper of Shan et al (2005), dried 
O. vulgare was given a TEAC value of 100.7 mmol/100g. The values reported for 
different food products by Halvorsen et al (2006) can, however, within the study be 
used to rank the samples in order of antioxidant activity (Van den Berg et al, 1999). 
Even though the analytical techniques have developed side by side with the 
growing knowledge of polyphenols, no ultimate information on dietary intake of 
polyphenols is available. Challenges lay in the chemical complexity of this group 
of compounds; the range of polyphenolic compounds is not yet fully covered. 
Another difficulty is related to the fact that no official agreement exists on the 
analytical methodologies, resulting in pieces of data that are hard to compare and 
combine. About 30 years ago, the estimate for the average daily intake of 
flavonoids in United States (US) was around 1g (Kühnau, 1976). Later on, the 
proposed figures for the intake of some individual flavonoids or flavonoid groups 
in Europe or in the US have been of the magnitude of tens of milligrams (Hertog et 
al, 1993b; Hertog et al, 1997; Leth & Justesen, 1998; Yochum et al, 1999; Arts et 
al, 2001a; Knekt et al, 2002; Sesso et al, 2003). In the 1997 Dietary Survey of 
Finnish Adults (National Public Health Institute, 1998) the average total intake of 
flavonoids in Finland was estimated to be 55 mg/d. The main contributing sources 
were fruits (67%), followed by tea, wine and other beverages (altogether 25%), 
vegetables (5%) and berries (3%). In a recent population based study of middle-
aged eastern Finnish men, Mursu et al (2007) reported the mean flavonoid intake to 
be 129 mg/d; of this figure, 84% were catechins, which were not included in the 
earlier intake calculations. The intakes of other flavonoids were significantly lower: 
flavonols, anthocyanidins and flavanones had a 7%, 6% and 3% contribution to the 
total intake, respectively. In Finnish diet, especially berries are a significant source 
of anthocyanins (Heinonen, 2007). Recent estimates for the intake of anthocyanins 
and proanthocyanidins are around few hundred milligrams (Gu et al, 2004; Manach 
et al, 2004). The lower intake figures, for example in Finnish diet, are most 
probably due to a limited number of compounds included in the calculations. In 
national FINDIET 2002 study, the consumption of fruits, vegetables and berries 
was found to be higher among Finnish women than in men (National Public Health 
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Institute, 2003). In all parts of Finland, oranges or orange juice were the most 
frequently consumed fruits / fruit products. Also apples were among the three most 
frequently used fruits / fruit products throughout Finland. 
Another remarkable source of polyphenols in Finnish diet is coffee, average 
consumption of which is several cups per day. The intake of phenolic acids from 
coffee may rise up to several hundreds of milligrams, the main compound being 
chlorogenic acid (Clifford, 1999). In addition to the most commonly occurring 
chlorogenic acid, high amounts of phenolic acids such as ferulic acid, caffeic acid 
and p-coumaric acids are also present e.g. in cereals, vegetables, fruits and berries 
(Rice-Evans et al, 1996; Macheix & Fleuriet, 1998; Clifford, 1999; Kaur & 
Kapoor, 2001; Manach et al, 2004). The intake of phenolic acids has been studied 
much less as compared to flavonoids. Based on their wide distribution in 
commonly consumed dietary plants and plant products, they must make a 
significant contribution to the daily intake of phenolic compounds; according to 
one estimation, they might account for on third of the daily polyphenol intake 
(Schwedhelm et al, 2003). 
 
2.3.5. Bioavailability and metabolism of phenolic compounds 
 
In order to exert systemic effects in the human body, polyphenols need to be 
absorbed from the GI tract and distributed in blood circulation and target tissues. 
Thus, knowledge on the bioavailability and metabolism of these compounds is 
essential as their potential bioactivities are evaluated. Due to the structural diversity 
of phenolic compounds, this area has not been easily covered. Until 1990´s, the 
absorption of phenolic compounds from the GI tract was believed to be marginal. 
After Hollman et al (1995) published their findings on the absorption of quercetin, 
this field has been intensively studied. However, more knowledge is still needed on 
these topics in humans. This review mainly focuses on those compounds most 
relevant in the context of this study. 
Several mechanisms are involved in the absorption of dietary phenolic compounds, 
the main mechanism in the permeation being passive diffusion (Scalbert & 
Williamson, 2000). Once ingested, polyphenols are exposed to acidic and digestive 
enzyme rich conditions of stomach. A small portion of aglyconic phenolic 
compounds may be absorbed from the stomach, but due to lack of glucosidases in 
gastric fluid, glycosides usually proceed to the small intestine. As an exception, 
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anthocyanins have been shown to be absorbed as intact glycosides from stomach 
(McGhie & Walton, 2007). Absorption from rat stomach has been shown for ferulic 
acid, p-coumaric acid, caffeic acid, chlorogenic acid and gallic acid (Konishi et al, 
2006). 5 minutes after the administration of these compounds by gastric intubation, 
plasma concentrations were increased in the following order: gallic acid = 
chlorogenic acid < caffeic acid < p-coumaric acid = ferulic acid. This matched the 
earlier results from Caco-2 cell work of Konishi et al (2003), Konishi & Shimizu 
(2003) and Konishi & Kobayashi (2004a), according to which the absorption of 
ferulic acid, p-coumaric acid and, to a lesser extent, caffeic acid, involved active 
transportation by monocarboxylic acid transfer mechanism, MCT. The affinity of 
gallic acid, which has a slow gastric absorption rate, for MCT is low, and esterified 
phenolic acids, for example chlorogenic acid, have no affinity to MCT at all. The 
main mechanism in the absorption of caffeic acid and rosmarinic acid in Caco-2 
cells was paracellular diffusion, (Konishi & Kobayashi, 2004b; Konishi & 
Kobayashi, 2005), and also passive diffusion was involved. Two plasma peaks for 
ferulic acid were detected, first for the intact molecule at 5 minutes and another for 
conjugated ferulic acid at 15 minutes, which suggest two parallel mechanisms of 
gastric absorption for ferulic acid (Konishi et al, 2006). The first would be rapid 
permeation in the intact form and the other a slower permeation process for 
conjugated forms. Rosmarinic acid was not included in the list of analytes in this 
study, but as it is, similarly to chlorogenic acid, an ester of caffeic acid, one might 
expect it to have absorption properties close to those of chlorogenic acid. In another 
work of Konishi et al (2005), rosmarinic acid peaked in plasma 10 minutes after 
administration by gastric intubation to rats.  
In the small intestine, enzymes capable of breaking down glycosidic bonds in 
phenolic compounds are present. Many polyphenols occur in glycosylated forms, 
and the removal of the glycoside residues in the gut is expected to increase the 
intestinal absorption by diffusion (Scalbert & Williamson, 2000). Some 
polyphenols such as free phenolic acids, flavonoid aglycones and some flavonoid 
glucosides, for example quercetin glucosides, are absorbed in the small intestine by 
passive diffusion, but the majority is not (Manach et al, 2004). The MCT 
absorption is active also in the small intestine, and in the colon. When polyphenols 
enter the colon, the microbial metabolism becomes a key factor in the absorption 
and metabolism. The colonic microflora is, for example, responsible for the 
cleavage of esterified phenolic acids (Schwedhelm et al, 2003). After enzymatic 
microbial deconjugation of any phenolic conjugate reaching the colon, two possible 
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routes exist: absorption of intact polyphenol through epithelium of colon and 
subsequent transfer to blood circulation, either in the free aglycone form or in 
conjugated form, or microbial degradation of original polyphenol into lower 
molecular mass metabolites, which then are absorbed. After absorption, 
polyphenols are mainly bound to plasma albumin and methylated, sulphated or 
glucuronised in the liver (Manach et al, 2004). The conjugation may also occur in 
the intestinal mucosa. In human colon, caffeic acid and chlorogenic acid are 
metabolised into lower molecular weight compounds, namely m-
hydroxyphenylpropionic acid, 3,4-dihydroxyphenylpropionic acid and m-coumaric 
acid (Rechner et al, 2004). The absorption of these metabolites has been shown in 
Caco-2 cells to involve the MCT mechanism as well as paracellular diffusion 
(Konishi & Kobayashi, 2004b). In study of Rechner et al (2002a), the majority of 
in vivo phenolic compounds were reported to be derived from the colon 
metabolism, subsequently metabolised in the liver into glucuronides. The levels on 
intact conjugated polyphenols were considerably lower. Thus, bioavailability 
studies determining only the intact original compounds or their conjugates ignore 
the contribution of these colonic products. The discrepancy between very low 
detected absorption of procyanidins and their observed effects in intervention 
studies could possibly be explained by underestimation of their absorption by 
detection of the intact molecules or their conjugates in urine, leaving potentially 
bioactive microbial metabolites undetected. The mechanism(s) of action, extent and 
significance of the various metabolites need to be better established in the future. 
Usually, less than 1-26% of ingested flavonoids are found in human urine (0.4-
1.4% for flavonols, 0.5-6% for catechins, 2.5-26% for isoflavones and 1-7% for 
anthocyanins) (Scalbert & Williamson, 2000). This suggests that their intestinal 
absorption is limited, or that they are effectively metabolised either in tissues or by 
the colonic microflora (Bravo, 1998). In colon, flavonoids are metabolised into a 
variety of low-molecular weight phenolic compounds, for example 
hydroxyphenylpropionic acids, hydroxyphenylacetic acids and hydroxybenzoic 
acids (Winter et al, 1989; Manach et al, 2004). In addition to being excreted in 
urine, polyphenols may also be excreted in the bile in their original or metabolised 
form and be subject to further metabolism in the colon (Manach et al, 2005). 
Of the phenolic acid class, the bioavailability and metabolism of chlorogenic acid 
and caffeic acid have been studied most often (Manach et al, 2005). Of 1000 mg of 
caffeic acid ingested, 27% was reported to be excreted in urine (Jacobson et al, 
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1983). In another study, the percentages of absorbed caffeic acid and chlorogenic 
acid from small intestine of ileostomy subjects were 95% and 33%, respectively 
(Olthof et al, 2001). This suggests that part of chlorogenic acid is absorbed from 
the small intestine. Contrary to this observation, Nardini et al (2002) suggested 
chlorogenic acid from coffee to be metabolised into caffeic acid in the colon, and 
subsequently absorbed. However, the plasma maximum concentration of caffeic 
acid was observed 30 minutes after ingestion of coffee, which rather refers to 
absorption from the small intestine than from the colon. Furthermore, esterase 
activity capable of hydrolysing esters of hydroxycinnamic acids, such as 
chlorogenic acid or rosmarinic acid, has been found in mucosa-cell free extract of 
all areas of human small intestine (Andreasen et al, 2001), as well as in the colon, 
but not in tissues such as intestinal mucosa or liver, or biological fluids such as 
gastric fluid, duodenal fluid or plasma (Plumb et al, 1999; Olthof et al, 2001; 
Rechner et al, 2001). Despite the partial absorption of chlorogenic acid in the upper 
part of the GI tract, the major part of chlorogenic acid probably reaches the colon, 
where colonic microflora metabolises it into lower molecular weight phenolic 
compounds, such as m-coumaric acid and m-hydroxyphenyl-propionic acid, which 
are actively absorbed by MCT (Konishi & Kobayashi, 2004b). 
Dietary ferulic acid from tomatoes (Bourne & Rice-Evans, 1998) and beer (Bourne 
et al, 2000) were reported to be absorbed intact, with 11-25% of ferulic acid from 
tomatoes being excreted in urine The maximum urinary excretion was observed 7-8 
hours after the ingestion. The bioavailability of rosmarinic acid, characteristic 
phenolic acid in Lamiaceae herbs, has been evaluated in two human studies. In 
study of Nakazawa & Ohsawa (2000), only glucuronide conjugates of apigenin and 
2,4,5-trimethoxycinnamic were found in human urine after ingestion of Perilla 
frutescens extract, whereas rats excreted e.g. m-hydroxyphenylpropionic acid and 
conjugates of caffeic acid,  p- and m-coumaric acid, ferulic acid, luteolin and 
apigenin. After ingestion of 200 mg of rosmarinic acid in Perilla extract, about 6% 
of rosmarinic acid and its metabolites (methylated rosmarinic acid, caffeic acid, 
ferulic acid and m-coumaric acid) were excreted in urine of human volunteers 
(Baba et al, 2005). Among other compounds, intact rosmarinic acid was detected in 
plasma, with peak concentration at 30 minutes after the ingestion. Based on Caco-2 
cell work (Konishi & Kobayashi, 2005) and rat studies (Konishi et al, 2005), 
rosmarinic acid has been suggested to be absorbed mainly by paracellular diffusion. 
Also, as rosmarinic acid seemed to be resistent for mucosa esterases in Caco-2 
cells, majority of it was suggested to be degraded into lower molecular weight 
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compounds, such as m-coumaric acid and hydroxylated phenylpropionic acids, in 
the colon, followed by efficient absorption e.g. by active MCT mechanism. 
To conclude, the molecular properties of phenolic substances greatly affect their 
rate and extent of intestinal absorption as well as the range of metabolites in plasma 
and urine (Bravo, 1998; Scalbert& Williamson, 2000; Manach et al, 2004). As 
dietary polyphenols enter human body, they are effectively metabolised to 
antioxidatively less active molecules (Rechner et al, 2002a; Masella et al, 2005). 
Even though polyphenols seem to be low in toxicity, they still are xenobiotics to 
human body and are treated as ones. The bioavailability of most polyphenols is 
rather low (Manach et al, 2005). Even though most phenolic acids and flavonoids 
are at least to some extent absorbed through the GI tract, the plasma concentrations 
of individual compounds are usually less than 1μmol/L; this is partially due to 
intensive metabolism by tissues and colonic microflora (Scalbert & Williamson, 
2000; Rechner et al, 2002b; Manach et al, 2005). Concentrations of polyphenols 
and their metabolites in vivo are lower than those of other antioxidants such as 
ascorbic acid and α-tocopherol (Schwedhelm et al, 2003; Manach et al, 2005; 
Williamson et al, 2005). For example, ascorbic acid is present in plasma or serum 
at level of 50-70 μmol/L and α-tocopherol between 20-30 μmol/L (Schwedhelm et 
al, 2003). As the plasma antioxidant capacity has been shown to be around 1 
mmol/L or more, it seems rather unlikely that a 1 μmol/L addition of a polyphenol 
would have remarkable effects (Halliwell, 2007). However, epidemiological 
observations on the cardiovascular protection as well as antioxidant and 
cardiovascular protective properties in intervention studies suggest that polyphenols 
are health beneficial, via antioxidant or some other mechanism. 
In order to maintain high concentrations of phenolic compounds in plasma, several 
doses should be ingested daily (Van het Hof et al, 1999). This is especially true for 
compounds with rapid absorption, metabolism and excretion pattern; metabolism 
and uptake in the colon results in prolonged half-lives (Schwedhelm et al, 2003). 
The absorption also depends on the matrix the compounds are present in; for 
example, ferulic acid is absorbed slower from cereals than from beer (Andreasen et 
al, 1999; Bourne et al, 2000). Furthermore, foods and their phytochemicals present 
in the GI tract may slow or inhibit the absorption (Manach et al, 2004). 
Another perspective for polyphenols not being fully absorbed is that they have the 
potential for antioxidant action within the GI tract. Present in high concentrations in 
the stomach, they might exert local antioxidant effects by scavenging various types of 
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reactive species or chelating transition metal ions (Halliwell, 2007). This could also 
occur in the small intestine, and even more, in the colon, as ascorbic acid and α-
tocopherol are mainly absorbed in the small intestine, polyphenols remaining the 
main group of dietary antioxidants present (Halliwell, 2007). Especially smaller 
molecular size metabolites of polyphenols are present in high concentrations in the 
colon (Jenner et al, 2005). In addition to their potential radical scavenging or metal 
chelating action, their inhibitory effects on e.g. oxidizing enzymes and matrix 
metalloproteinases might be beneficial for the local health of colon. 
 
2.4. LAMIACEAE HERBS 
 
2.4.1. What are Lamiaceae herbs? 
 
Lamiaceae (syn. Labiatae) herb family consists of more than 200 genus and 3500 
species (Watson & Dallwitz, 2007). These herbs have been used also in traditional 
medicine, but are mainly known for their culinary properties. For example oregano, 
rosemary, sage and thyme used in this study are typical seasonings in the 
Mediterranean region, and especially oregano is consumed in larger quantities all 
around the world as part of pizza seasoning mix. Oregano, rosemary, sage and 
thyme have a GRAS status given by the U.S. Food and Drug Administration (U.S. 
Food and Drug Administration, 2006), meaning that they are generally recognised 
as safe for human consumption without limitations on intake. This fact, combined 
with promising data on the antioxidant properties of phenolic compounds, has 
triggered both scientific and commercial interest towards this herb family.  
 
2.4.2. Phenolic compounds in Lamiaceae herbs 
 
Lamiaceae herbs are rich in polyphenols: compounds from several classes: di- and 
triterpenes, simple phenolics, phenolic acids and flavonoids are found in 
representatives of this family of herbs. From sage, for example, more than 160 
different phenolic constituents have been identified (Lu & Foo, 2002). This review 
focuses on partial characterisation of the phenolic profiles of Lamiaceae herbs used 
in this study: Rosmarinus officinalis L. (R. officinalis), Salvia officinalis L. (S. 
officinalis), Thymus vulgaris L. (T. vulgaris), Origanum vulgare L. (O. vulgare) 
and Origanum onites L. (O. onites). Some of the identified phenolic compounds in 
these herbs are presented in Table 3.  
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Table 3. Some phenolic constituents found in Lamiaceae herbs. 
 
Herb Identified phenolic(s)  Reference 
R. officinalis luteolin, hesperidin Okamura et al, 1994 
  carnosic acid, carnosol Bicchi et al, 2000 
  p-hydroxybenzoic, syringic, vanillic, 
protocatechuic and  caffeic acid 
Zgórka & Głowniak, 2001 
  
  rosmarinic acid Cuvelier et al, 1996 
  gallic, p-coumaric, ferulic, chlorogenic 
and  dihydroxycaffeic acid 
Kivilompolo et al,2007 
S. officinalis carnosol, carnosic acid, rosmanol, epi-
rosmanol, rosmadial, methyl carnosate 
Cuvelier et al, 1994 
  p-hydroxybenzoic and caffeic acid Wang et al, 2000 
  protocatechuic acid  Zgórka & Głowniak, 2001 
  vanillic, ferulic and rosmarinic acid Cuvelier et al, 1996  
 
  
salvianolic acids 
(rosmarinic acid dimers) 
Lu & Foo, 1999 
  p-coumaric acid Lu & Foo, 2000 
 
  
gallic, vanillic, chlorogenic and 
dihydroxycaffeic acid 
Kivilompolo et al, 2007 
  apigenin, luteolin, hesperetin Cuvelier et al, 1996 
  kaempferol  Shan et al, 2005 
T. vulgaris p-hydroxybenzoic and vanillic acid Zgórka & Głowniak, 2001 
 
  
protocatechuic, syringic, caffeic, 
p-coumaric, ferulic, rosmarinic and 
dihydroxycaffeic acid 
Kivilompolo et al, 2007 
  chlorogenic acid Kivilompolo & Hyötyläinen, 2007 
  apigenin, luteolin Justesen & Knuthsen, 2001 
O. vulgare
  
p-hydroxybenzoic, vanillic, caffeic, 
o-coumaric and ferulic acid 
Gerothanassis et al, 1998 
 
 
  
gallic, vanillic, caffeic,  p-coumaric, 
ferulic, rosmarinic, chlorogenic and  
dihydroxycaffeic acid 
Kivilompolo et al, 2007 
 apigenin, luteolin Justesen & Knuthsen, 2001 
 quercetin Exarchou et al, 2002 
 kaempferol Shan et al, 2005 
  eriodictyol, naringenin Exarchou et al, 2003 
O. onites
  
p-hydroxybenzoic, vanillic, caffeic 
and ferulic acid 
Gerothanassis et al, 1998 
 rosmarinic acid Pizzale et al, 2002 
  apigenin, luteolin Kosar et al, 2003 
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In polar extracts of Lamiaceae herbs, phenolic acids are the major class of phenolic 
compounds. Phenolic acids (caffeic acid, gallic acid, p-coumaric acid and 
rosmarinic acid, depending on the herb in question) were reported to be the major 
type of phenolic compounds in methanolic extracts of O. vulgare, thyme, rosemary 
and sage in study of Shan et al (2005). The major part of aqueous sage extract 
phenolics consists of phenolic acids, mainly caffeic acid derivatives (Lu & Foo, 
2002). The amounts of phenolic acids in these herbs varies, depending on the herbs 
in question, from tens of milligrams per 100 grams of herb to even tens of 
milligrams per 1 gram of herb; flavonoids are present at the level of few milligrams 
to tens of milligrams per 100 g (Justesen & Knuthsen, 2001; Shan et al, 2005; 
Kivilompolo et al, 2007). The total phenolic values of methanolic Lamiaceae 
extracts, determined as gallic acid equivalents, are in the range of 5-10 g gallic acid 
equivalent (GAE)/100g dry weight (Shan et al, 2005). Rosmarinic acid, the major 
phenolic component of most Lamiaceae extracts, may even reach concentrations in 
the range of 1-2.5 g/100g dry weight (Shan et al, 2005). The concentrations 
determined show wide variation between studies. In addition to phenolic acids, 
phenolic diterpenes such as carnosic acid and carnosol were reported especially in 
rosemary and sage, and to a lesser extent, in thyme. Also some amounts of volatile 
compounds, for example carvacrol and thymol, as well as flavonoids were found in 
all four extracts. Rosmarinic acid has been identified as the predominant phenolic 
compounds in aqueous extracts of sage and thyme (Zheng & Wang, 2001) and in 
60% ethanol extracts of oregano, sage, rosemary and thyme (Kivilompolo & 
Hyötyläinen, 2007). The phenolic content of these herbs depends e.g. on the 
growing location and harvesting time, as was seen for rosmarinic acid (Yesil-
Celiktas et al, 2007). 
 
2.4.3. Lamiaceae herbs as a source of dietary antioxidants 
 
Lamiaceae herbs have been reported to contain high levels of dietary antioxidants 
(Zheng & Wang, 2001; Dragland et al, 2003; Shan et al, 2005; Halvorsen et al, 
2006), and the in vitro antioxidant potency of these herbs has been revealed in 
numerous studies (Exarchou et al, 2002; Pizzale et al, 2002; Dorman et al, 2004). 
In Norwegian-Japanese study of Dragland et al, an intake of 1 gram of these herbs 
has been suggested to make a relevant contribution (>1mmol) to the total intake of 
plant antioxidants, and even to be a better source of dietary antioxidants than many 
other food groups. Among the 50 food products with the greatest TEAC values, 13 
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spices were found, oregano having the second highest antioxidant value after cloves 
(Halvorsen et al, 2006). 
The total use of herbs as well as type of herbs used varies largely in different 
countries. Lamiaceae herbs are typical seasoning ingredients in the Mediterranean 
countries, in which they are regularly consumed in amounts higher than in Finland. 
The incidence of CVD in countries of southern Europe, such as Spain, Italy, France 
and Greek, is lower than in countries in northern Europe or The United States 
(Serra-Majem et al, 2006). The explanation for the observed difference has most 
often been the diet traditionally consumed in the countries of the Mediterranean 
region. The diet is characterised by the following eight components: high 
monounsaturated to saturated fat ratio, high consumption of legumes, cereals 
(including bread), fruit, vegetables and red wine, moderate consumption of milk 
and other dairy products, and low consumption of meat and meat products 
(Trichopoulou et al, 1999; Lairon, 2007). It is rich in fibre, unsaturated fats and 
polyphenols, and has been described as an optimal diet for cardiovascular 
protection. In addition to an established positive association between Mediterranean 
diet and CVD, observational studies have found positive association between the 
consumption of the aforementioned diet and longevity. Furthermore, a negative 
association between the diet and certain cancers and other nutrition-related diseases 
has been established (Serra-Majem et al, 2006). The credibility of these studies has, 
however, suffered from low numbers of study participants as well as differences in 
the methodology used to define the intervention. As reviewed by Estruch et al 
(2006) and Lairon (2007), the results from intervention studies are conflicting. In 
2006, preliminary results from the first large-scale, long-term (about 5 years) 
clinical trial on the effects of Mediterranean diet enriched with extra virgin olive oil 
or nuts in 9000 high-risk patients for CVD in Spain were published (Estruch et al, 
2006). At three-month time point from the beginning of the study, the two groups 
with oil/nuts enriched Mediterranean type diet showed, compared to the low-fat 
diet group, beneficial changes in the following intermediate markers of 
cardiovascular disease: plasma glucose levels, systolic blood pressure and total 
cholesterol/HDL cholesterol ratio. In the group consuming olive oil enriched 
Mediterranean diet also plasma levels of C-reactive protein, an inflammatory 
marker, were decreased. Even though this short-term substudy of the long-term 
study did not detect the clinical outcomes, it showed that consumption of enriched 
Mediterranean diet favourably affects intermediate outcomes of CVD. However, 
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the contribution of polyphenols to observed cardiovascular protection could not be 
distinguished from that of PUFAs or dietary fiber. 
The consumption of fresh herbs in Finland has increased and diversified during the 
recent years. One of the strongest factors contributing to the increased consumption 
is that pot-grown herbs are today available throughout the year. Furthermore, the 
international trends in cooking have introduced new herbs into Finnish kitchens. 
Instead of using herbs as seasoning just in cooked dishes, the polyphenol and 
antioxidant content, as well as flavour, of different salad dishes might be markedly 
enriched by additions of fresh herbs (Ninfali et al, 2005). Considering their high 
content of polyphenols with a significant contribution to the dietary antioxidant 
intake, the regular use of fresh and dried herbs from the Lamiaceae family may help 
one to assemble a healthy, balanced diet rich in health-beneficial phytochemicals. 
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3. AIMS OF THIS STUDY 
 
During the past twenty years, intensive research has been focused on the oxidation of 
biomolecules and the potential health promoting or disease preventing effects of dietary 
antioxidant polyphenols abundant in fruits and vegetables. Lamiaceae herbs with a 
traditional culinary usage especially in the Mediterranean region are rich in antioxidant 
phenolic compounds, but a very little is known about their potential health effects in 
humans. This study on the antioxidant properties of Lamiaceae herbs represents a 
progression starting from finding an extraction technique applicable for producing 
extracts suitable for use as nutritional supplements, proceeding to evaluation of the 
antioxidant properties of these extracts and their phenolic constituents in laboratory test 
models, and finally ending up in elucidating their bioavailability, metabolism and 
effects on lipid peroxidation biomarkers in humans. 
 
The aims of the present work were: 
 
1) To study the use of different techniques to extract Lamiaceae herbs with 
 emphasis on finding a technique for producing antioxidant-rich extracts with 
 properties suitable for human consumption, 
 
2)  to study the antioxidant properties of these extracts and phenolic constituents 
 and metabolites thereof in different in vitro models,  
 
3)  to examine the bioavailability and metabolism of phenolic acids from 
 oregano extract in humans, and 
 
4) to study the short and long term effects of oregano extract on biomarkers of 
 antioxidant capacity and lipid peroxidation in humans.     
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4. MATERIALS AND METHODS 
 
4.1. Standard compounds and reagents 
 
The standard compounds used and their origins of purchase are presented in Table 4. 
The purity of all the standards used was 98% or higher, and all other reagents 
(origins presented in original publications) were of analytical or HPLC grade. 
Water used was purified using a Millipore RO 12 plus system (Millipore Corp., 
Bedford, MA, US).   
 
Table 4. Standard compounds used and their origins of purchase. 
 
Compound     Origin of purchase 
1,3-dihydroxybenzene (resorcinol) Riedel-de-Hagen 
p-hydroxybenzoic acid Extrasynthese
2,3-dihydroxybenzoic acid Fluka
2,4-dihydroxybenzoic acid Fluka
2,5-dihydroxybenzoic acid Fluka
2,6-dihydroxybenzoic acid Fluka
3,4-dihydroxybenzoic acid (protocatechuic acid) Sigma
3,5-dihydroxybenzoic acid Fluka
3,4,5-trihydroxybenzoic acid (gallic acid) Sigma
4-hydroxy-3-methoxybenzoic acid (vanillic acid) Fluka
4-hydroxy-3,5-dimethoxybenzoic acid (syringic acid) Sigma
m-hydroxyphenylacetic acid Sigma
3,4-dihydroxyphenylacetic acid Sigma
m-hydroxyphenylpropionic acid Apin chemicals
3,4-dihydroxyphenylpropionic acid Apin chemicals
o-coumaric acid Sigma
m-coumaric acid Fluka
p-coumaric acid Sigma
caffeic acid Sigma
4-hydroxy-3-methoxycinnamic acid (ferulic acid) Sigma
sinapic acid Sigma
rosmarinic acid Extrasynthese
chlorogenic acid Sigma
catechin Sigma
epicatechin Sigma
catechin gallate Sigma
epicatechin gallate Sigma
epigallocatechin Sigma
epigallocatechingallate Sigma
gallocatechin Sigma
apigenin Fluka
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apigenin-7-O-β-glucoside Extrasynthese
eriodictyol Apin chemicals
fisetin Sigma
hesperetin  Sigma
isorhamnetin Apin chemicals
kaempferol Sigma
luteolin Sigma
luteolin-7-O-glucoside Extrasynthese
myricetin Sigma
naringenin Apin chemicals
naringin Sigma
quercetin Sigma
rhamnetin Apin chemicals
rutin Sigma
 
4.2. Plant material 
  
Representatives of four genus of Lamiaceae herb family were used in this study: S. 
officinalis (sage, study I), R. officinalis (rosemary, study II), T. vulgaris (thyme, 
study II), O. vulgare (oregano, studies II and V) and O. onites (oregano, studies III 
and IV).  O. vulgare and O. onites are two oregano species of the major culinary 
importance. Their nomenclature and synonyms are rather confusing, as both are 
often referred to as pot marjoram. O. vulgare in grown all over the Europe and has 
thus been called European oregano, whereas O. onites is grown especially in 
Greece and Crete and has thus been called Greek or Cretan oregano. All the herbal 
material, consisting of aerial parts of these herbs was received air-dried and cut in 
air-tight plastic containers from Teriaka Ltd, Helsinki, Finland and stored at room 
temperature. As an exception to other herbal samples, O. onites material was pre-
treated by a steam-distillation procedure by Türer Ltd, Izmir, Turkey. 
 
4.3. Extraction techniques for the plant material (I) 
 
In study I, the extraction of phenolic antioxidants from sage was studied using four 
different extraction methods: pressurised hot-water extraction (PHWE), extraction 
with methanol, 70% ethanol and hydrodistillation. The details on extraction 
techniques other than the hydrodistillation used in the production of the study 
extracts are presented in study I. For the hydrodistillation, 50 g of dry herb material 
was boiled with 500 ml of water in a round-bottom flask connected to a Ph Eur 
hydrodistillation apparatus for two hours. The water was removed and 300 ml of 
pure water added, following which the herb material was further boiled for one 
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hour. During the two-step boiling the volatile components were removed from the 
plant material. The plant material was removed by filtering and the water fractions 
were combined, freeze-dried and stored at 4ºC until used. 
 
4.4. Studies on the antioxidant properties of Lamiaceae extracts and phenolic 
constituents and metabolites of O. onites in vitro (I-IV) 
 
Analysis of total phenols in the study extracts. The total phenolic compounds in the 
study extracts were determined as GAE (Singleton et al, 1999). A weighed amount 
of dry extract was dissolved into accurate volume of water, and the solution was 
transferred to a volumetric flask. Water and undiluted Folin-Ciocalteu reagent were 
added and after 1 min, 20% (w/v) Na2CO3 was added and the flask was filled up to 
volume with H2O. In the reaction, reducing substances in the sample react with 
Folin-Ciocalteu reagent, resulting in formation of chromogens which can be 
spectrophotometrically measured at 760 nm.  After 1 h incubation at 25 °C, the 
absorbance of the solution was measured at 760 nm and the GAE value calculated 
using a calibration curve prepared previously with gallic acid. The GAE values are 
the mean of duplicate analyses. 
1,1-Diphenyl-2-picrylhydrazyl (DPPH•) scavenging assays. The ability of the 
samples to scavenge free radical DPPH• was determined spectrophotometrically by 
measuring a decrase in the absorbance caused by the radical at 517 nm. As an 
antioxidant donates an electron to a DPPH• radical molecule, the purple colour and 
corresponding absorbance of the radical at 517 nm disappears. Two DPPH• assays 
were used: In study II, assay of Gyamfi et al, 1999 was used and in study IV, the 
assay of Goupy et al, 1999 was employed. The principle of these two assays is the 
same, the main difference being that in the former, the reaction solution is buffered. 
Briefly, for the assay in study II the extracts were diluted in Tris-HCl (2-amino-2-
[hydroxymethyl]-1,3-propanediol –hydrochloric acid) buffer to a concentration 
series and methanolic DPPH• solution was added. Control consisted of buffer and 
DPPH• in methanol. After a 30 minute reaction period, the absorbance of the 
solutions was recorded at 517 nm. The percentage inhibition (PI) of the radical 
absorbance was calculated as follows: PI = [(Abscontrol-Abssample)/Abscontrol] x100. 
The IC50 value (sample concentration yielding a 50% inhibition of the radical 
absorbance) was then estimated using Sigma-Plot 2001 (version 7.0, SPSS Inc., 
Chicago, IL, US). The results were expressed as IC50(mg/mL). In study IV, samples 
were diluted to a concentration series in methanol, and methanolic DPPH• solution 
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was added. After 30 minutes, the absorbance of control and samples at 517 nm was 
determined.  The (PI) of the radical absorption was calculated as described above. 
The IC50 values were calculated using the equation IC50 = C1 - ΔC, where ΔC = [(C1 
– C2) x (PI1 – 50)]/(PI1 – PI2) and PI1 is the antioxidant activity value superior to 
50% inhibition and PI2 is inferior to 50% inhibition; C1 and C2 are the sample 
concentrations corresponding to PI1 and PI2, respectively. The results were 
expressed as 1/ IC50(mg/mL) values. 
Fe3+ to Fe2+ reduction capacity assay. The reductive capacities of the extracts were 
assessed using ferric to ferrous reductive activity as determined 
spectrophotometrically from the formation of Perl’s Prussian blue coloured -
complex (Yildirim et al, 2000). Extracts were diluted in distilled water, phosphate 
buffer (pH 7.0) and 1% (w/v) potassium ferricyanide [K3Fe(CN6)] solution were 
added. After a 30-minute incubation at 50ºC, trichloroacetic acid (10%, w/v) was 
added and the mixture was centrifuged for 10 minutes. Finally, a volume of the 
upper layer was mixed with water and FeCl3 solution (0.1%, w/v), and the 
absorbance was recorded at 700 nm. The results were expressed as relative 
reduction efficiency as compared to ascorbic acid. 
ABTS•+ decolourisation assay. The determination of ABTS•+ radical scavenging 
was carried out as described by Re et al, 1998. The ABTS•+ radical was produced 
by reacting aqueous ABTS solution with K2S2O8 solution in the dark for 12–16 h 
at ambient temperature, and adjusting the UV absorbance at 734 nm to 0.700 (± 
0.020) with water at 30°C. The extracts were diluted into a concentration, in which 
sample added to ABTS•+ resulted in a 20% - 80% inhibition of the blank 
absorbance. After ABTS•+ was added to extract samples and Trolox™ standards, 
the absorbance at 734 nm was recorded at 1 min intervals for 10 minutes. The 
percentage inhibition of the blank absorbance was plotted as a function of 
concentration and the TEAC value was calculated using Trolox™ calibration curve. 
Fe3+-EDTA/H2O2/ascorbate-catalysed deoxyribose oxidative degradation assay. 
The determination of OH• scavenging was carried out as described by Halliwell et 
al, 1987. A reaction mixture containing deoxyribose, phosphate buffer, extract, 
FeCl3, EDTA (ethylenediamine tetraacetic acid), H2O2 and ascorbic acid was 
incubated at 37°C for 60 min. Butylhydroxytoluene, trichloroacetic acid and 
thiobarbituric acid (TBA) were added and the incubation was continued for 20 min 
at 80°C. The reaction was stopped by ice bath. Butanol was added, the tubes were 
vortexed and centrifuged for 10 minutes. The degree of deoxyribose degradation 
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was finally determined by measuring the absorbance of the organic layer at 532 nm. 
If the extract was capable of inhibiting the oxidative degradation of deoxyribose, 
the absorbance was lower ar compared to that of the control. The PI was calculated 
as follows: PI = [(Abscontrol-Abssample)/Abscontrol] x100. 
Copper-induced LDL oxidation assay. The ability of the herbal extracts or single 
phenolic compounds to inhibit or delay the CuSO4 -induced oxidation of LDL 
unsaturated fatty acids in vitro was assessed using a microwell-plate modification 
of the method by Esterbauer et al, 1989. A detailed presentation of the method is 
presented in study II. EDTA-plasma was separated from blood of healthy 
volunteers by centrifugation, following which the very low density lipoprotein 
(VLDL) and LDL fractions were isolated in a density gradient (cut-off densities 
d<1.006 g ml-1 and 1.006<d<1.063 g ml-1, respectively) by sequential 
ultracentrifugation (Havel et al, 1955). The LDL fraction was carefully collected, 
packed into cryo-tubes and stored at -80 ºC until used (maximum 2 months). Prior 
to the oxidation experiment, the EDTA used as a metal chelator was removed from 
the LDL fraction in Sephadex G-25 columns (Pharmacia Biotech, Uppsala, 
Sweden) using phosphate-buffered saline (PBS) as the eluent. After the removal of 
EDTA, the protein content of LDL fraction was determined by a method modified 
from that of Lowry et al, 1951 using BioRad Protein Assay Reagents (BioRad 
Laboratories, Hercules, CA, US) on a Perkin Elmer HTS7000+ BioAssay Reader 
(Buckinghamshire, United Kingdom) at 750 nm. Finally, the protein concentration 
was adjusted to 105 μg/mL with PBS. For the oxidation, diluted LDL was pipetted 
on UV microtiter plate. The extracts diluted in water or single compounds diluted 
in ethanol were added to wells (except for the control), and the oxidation was 
initiated by aqueous CuSO4 solution. The oxidation of LDL was assessed by 
measuring the formation of PUFA oxidation products, conjugated dienes, at 235 
nm with the Perkin Elmer BioAssay Reader. The state of oxidation was followed at 
three minute intervals for 10 hours or 16 hours, depending on the samples in 
question. The duration (min) of the lag phase, i.e. the time preceding the 
propagation phase of the oxidation, was calculated from the intercepts of the 
tangent lines in the oxidation curves. 
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4.5. Human studies (III, V) 
 
The human studies and analyses presented in the original publications III and V 
were carried out in the Research Institute of Public Health, University of Kuopio.  
 
4.5.1. Kinetic study (III) 
 
Subjects and study design 
 
Six volunteers (four women and two men) aged 28-38 years with normal health (no 
chronic diseases or regular use of antioxidant supplements or medication, body mass 
index (BMI) <32 kg/m2) were recruited for this study among the staff of Research 
Institute of Public Health, Kuopio. For 7 days before the experiment, the subjects 
consumed a diet poor in phenolic compounds. This low-phenolic diet consisted 
mainly of dairy products, meat, fish, chicken, potato, pasta, rice and white bread, and 
was continued for the duration of the follow-up time. To determine the baseline 
urinary excretion of phenolic acids, 24-hour urine was collected before the 
experiment. At 0 hours the participants ingested a single dose (3.75 g) of O. onites 
extract packed in hard-gelatine capsules. This dose corresponds to 13.9 g of dried 
herb. All aliquots of urine production were collected at 2, 4, 6, 8, 12, 24, 30, 36 and 
48 hour intervals after the ingestion of the extract. The volume of the collected urine 
samples was determined and aliquots of 2x10 mL were stored at –70 °C until 
analysed. 
 
Analyses of  O. onites extract and urine 
 
HPLC apparatus and analytical conditions. Analyses were carried out with high 
performance liquid chromatography (HPLC) using coulometric electrode array 
detector (CEAD) (ESA Inc. Chelmsford, MA, US). HPLC system consisted of two 
pumps, autosampler with cooled sample tray and a thermostat chamber (37 °C) for 
columns and the detector. The detector consisted of two detector cells each 
containing four electrode pairs (channels) and one reference electrode to measure 
the background signals. A different potential was set on each channel to oxidize the 
analytes of interest. The potentials of channels 1-8 selected according the 
electrochemical properties of the analytes to achieve the highest sensitivity possible 
were 20, 100, 320, 390, 570, 600, 630 and 680 mV, respectively.  
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The mobile phase consisted of two eluents A: 50 mM KH2PO4/H3PO4 buffer pH 
2.3:methanol (90:10, v/v) and B: 50 mM KH2PO4/H3PO4 buffer pH 
2.3:methanol:acetonitrile (40:40:20, v/v/v). The flow rate was 0.3 mL/min and 
different gradient elution for the extract and urine samples was used. The injection 
volume used was 10 μl. The following columns were employed: guard column 
Quick Release C18 (Upchurch Scientific Inc., WA) 10 x 3 mm packed with 5 μm 
particles and analytical column Inertsil ODS-3 (GL Sciences Inc., Japan) 150 x 3 
mm packed with 3 μm end-caped particles. Limits of detection (LOD) and linear 
ranges for signals were determined to evaluate the suitability of the detection 
conditions for phenolic acids in urine and in O. onites extract. The oregano extract 
was screened for the presence of the 45 compounds presented in Table 4. Based on 
the phenolic acid composition of the extract, the following phenolic acids were 
analysed from urine samples: p-hydroxybenzoic acid, protocatechuic acid, gallic 
acid, syringic acid, vanillic acid, m-hydroxyphenylacetic acid, 3,4-
dihydroxyphenylacetic acid, m-coumaric acid, p-coumaric acid, caffeic acid, ferulic 
acid, rosmarinic acid and chlorogenic acid. 
Sample pre-treatment for oregano extract. An amount of dry O. onites extract was 
weighed and water was added, followed by ascorbic acid and hydrolysis reagent 
containing 2 500 U/mL of β-glucuronidase from Helix pomatia in sodium acetate 
buffer pH 4.1. Sample was incubated at 60 °C for 2 hours. Into cool sample, 
methanol was added, sample was shaken vigorously and centrifuged 10 min at 
2500 rpm. The supernatant was transferred into volumetric flask, which was filled 
up to volume with methanol. The resultant solution was further hydrolysed with 
sodium hydroxide for 1 h at 90 °C. Into cool sample, methanol was added and 
sample was centrifuged 10 min at 2500 rpm. Supernatant was transferred into 
volumetric flask, which was filled up to volume with methanol. Both fractions were 
diluted with mobile phase prior to the HPLC run.  Sodium hydroxide treatment was 
applied to quantify the total amount of ferulic acid present in the extract. 
Rosmarinic, protocatechuic, gallic, chlorogenic, caffeic, sinapic, p-, m-, and o-
coumaric acids were quantified after the enzyme hydrolysis. Also m-hydroxy- and 
3,4-dihydroxyphenylacetic acids were measured from the extract to confirm their 
presence merely in the urine samples, thus being pure in vivo metabolites. A 
weighed amount of O. onites extract was also dissolved in 80 % methanol and 
phenolic acids were measured after appropriate dilution to confirm the stability of 
the ester bond in rosmarinic acid molecules during the enzyme hydrolysis. 
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Sample pre-treatment for urine. Urine samples were thawed and 0.5 mL of urine 
was taken into analysis. Ascorbic acid was added, followed by 0.5 mL of enzyme 
hydrolysis reagent containing 2 500 U/mL of β-glucuronidase from Helix pomatia 
(Burgundy snail) in sodium acetate buffer pH 5. Sample was mixed and incubated 
overnight at 37 °C. Into cool sample, HCl was added and sample was extracted 
twice with diethyl ether in a multitube shaker (2 min at 2000-2500 rpm). The 
diethyl ether phase was separated after freezing the water phase. The extracts were 
combined, evaporated under nitrogen flow and dissolved in methanol. Prior to the 
HPLC run, the sample was diluted with eluent A. In each assay, a reagent blank 
containing water instead of urine was prepared and treated similarly with the 
samples. Helix pomatia enzyme mixture contained small amounts of some phenolic 
acids, thus the blank was subtracted from the samples. The recoveries of the 
phenolic acids were evaluated by adding standards into water and treating them 
similarly with the sample. Control sample was used to check the overall 
performance of the sample pre-treatment procedure.  
 
4.5.2. Supplementation study (V) 
 
Subjects, study design and supplement used 
 
45 non-smoking male volunteers from the Kuopio area were recruited for the 4-
week double-blinded supplementation trial using the following inclusion criteria: 
no severe obesity (BMI < 32 kg/m2), no regular use of medicines or nutritional 
supplements with antioxidant or lipid lowering properties, no chronic diseases like 
diabetes, CHD or other major illness, and willingness to consume 375 mL of the 
study beverage daily for 4 weeks. The subjects were randomly assigned to consume 
daily 375 mL of the study beverage: mango-orange juice (placebo group, n = 15), 
mango-orange juice enriched with oregano extract containing 300 mg GAE total 
phenolic compounds (low phenolic [LP] group, n = 15) or mango-orange juice 
enriched with oregano extract containing 600 mg GAE total phenolic compounds 
(high phenolic [HP] group, n = 15).  
The placebo juice was prepared from an orange-mango juice concentrate (Tekno-
Food, Finland). The concentrate was chosen to be used due to its very low 
antioxidant capacity and phenolic content (unpublished observations). To prepare 
the LP and HP juices, 5.35 g/L and 10.7 g/L of oregano extract were added in the 
placebo juice, respectively. The daily dose of study beverages consisted of three 
 62
125 mL brick packages, the daily dose of the oregano extract being 2 g in the LP 
group and 4 g in the HP group. These doses correspond to 5.55 g and 11.1 g of 
dried oregano, respectively. The subjects were instructed to consume beverages 
with meals, one package in the morning, one in the afternoon and one in the 
evening. The subjects were advised to refrain from consuming tea, red wine, cocoa 
and chocolate one week prior to and during the study and to avoid the use of 
alcohol and analgesics three days before and vigorous physical activity one day 
before the study visits. They were also given instructions for the four-day food 
recording that was demanded at the baseline and during the last week of the 
intervention period to control possible confounding factors and to check the 
compliance to given instructions. The regular consumption of study beverages was 
checked by a questionnaire designed for the study.  
In this work, both short- and long term effects of juice consumption were studied. 
The short-term study was conducted at the study baseline (day 0) before the long-
term supplementation study using the same subjects and study groups as in long-
term study. Blood samples were drawn at the baseline after an overnight (10 h) fast 
and 1.5 hours after the consumption of 250 mL (two tetra brick packages) of study 
juices. The same selection of analyses was carried out both in the short- and long 
term studies, i.e. at the baseline, 1.5 hours after ingestion of the first dose of study 
beverages and after the 4-week supplementation period. The subjects collected 24-h 
urine samples on the day preceeding to the baseline study visit, and during the last 
24 hours of the supplementation period. Volume of the urine was determined and 
aliquots were stored at -70 °C until urinary phenolic acids were determined.  
Determination of the total phenolic content and phenolic compounds in the O. 
vulgare extract and in the study beverages. The total phenolic content of the 
oregano extract was determined as described earlier in 4.4. The analyses of 
individual phenolic compounds in the extract and in the study juices were carried 
out as described in 4.5.1.   
Measurement of DPPH• radical scavenging capacity of the study beverages. The 
measurement of the DPPH• radical scavenging capacity of the study beverages was 
carried out as described in 4.4. (Goupy et al, 1999). The IC50 value means the 
dilution of each juice resulting in 50% inhibition of the radical absorbance, and the 
results are expressed as 1/IC50. 
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Measurements of oxidative stress and lipid peroxidation 
 
Plasma TRAP.  Plasma TRAP was determined from plasma with a method 
modified from (Metsä-Ketelä, 1991) as previously described by Nyyssönen et al, 
1997. Briefly, 2,2'-azobis(2-amidinopropane) dihydrochloride (AAPH) was added 
into luminol containing buffer and the formation of peroxyl radicals in the thermal 
decomposition of AAPH was followed with a luminometer (Model 1251, Bio Orbit 
Oy, Turku, Finland) at 32°C. After 15 minutes, plasma sample extinguishing the 
chemiluminescence was added, and the TRAP value was calculated from the 
duration of the absence of chemiluminescence.  
Resistance of serum lipids to oxidation.  The resistance of serum lipids to oxidation 
was measured as described earlier (Nyyssönen et al, 1997). In brief, serum was 
diluted in phosphate buffered saline, pH 7.4. Oxidation was initiated by an addition 
of CuCl2 into diluted, pre-warmed (30 °C) serum. The formation of conjugated 
dienes was followed by monitoring the change in the UV-absorbance at 234 nm on 
a Beckman DU-6401 spectrophotometer (Fullerton, California, US) equipped with 
a six-cuvette automatic sample changer. The absorbance was recorded every 5 min 
for 4 h. The lag-time was determined as the time period before the propagation 
phase (maximum rate of oxidation).  
Baseline conjugated dienes.  The oxidation of LDL in vivo was assessed as the 
amount of conjugated dienes as described previously (Ahotupa et al, 1998). In 
brief, serum LDL was isolated by precipitation with buffered heparin. The 
precipitate was re-suspended in phosphate buffered saline. The cholesterol 
concentration was determined and the rest of the suspension was used for the 
measurement of conjugated dienes. Lipids were extracted from the LDL by a 
mixture of chloroform and methanol (3:1), dried under nitrogen, re-dissolved in 
cyclohexane, and the amount of conjugated dienes was measured 
spectrophotometrically at 234 nm and 300 nm. The absorbance at 300 nm was 
subtracted from that at 234 nm to reduce background interference, and the 
concentration of conjugated dienes in LDL was calculated per concentration of 
cholesterol in LDL. 
Plasma F2-isoprostanes. The plasma free F2α -isoprostane concentrations were 
determined at Oy Jurilab Ltd., Kuopio, Finland. A deuterated prostaglandin F2α 
internal standard was added to plasma, and F2 α -isoprostanes were extracted with 
C18 and silica minicolumns. Compounds were converted to pentafluorobenzyl ester 
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trimethylsilylether derivates and analyzed by a gas chromatographic-mass 
spectrometric assay (Morrow & Roberts, 1994). 
 
Other laboratory measurements 
 
Safety measurements.  Serum alanine aminotransferase (ALAT, ALT/GPT Cat No 
981110, Thermo Electron, Vantaa, Finland) and creatinine (Creatinine, Cat No 
981811, Thermo Electron, Vantaa, Finland) were measured with a Kone Specific 
clinical chemistry analyzer (Thermo Electron, Vantaa, Finland). The catalytic 
concentration of gamma-glutamyltransferase (γ-GT, Cat no 981093, Thermo 
Electron, Vantaa, Finland) was measured using the International Federation of 
Clinical Chemistry method (Shaw et al, 1983) with Kone Specific clinical 
chemistry analyzer.  
Serum lipids and lipoproteins.  Serum cholesterol (Cholesterol, Cat No 981261, 
Thermo Electron, Vantaa, Finland) and triglycerides (Triglycerides GPO-PAP, Cat 
No 701904, Roche Diagnostics, Mannheim, Germany) were determined with 
enzymatic colorimetric tests using Kone Specific clinical chemistry analyzer. The 
serum concentration of high-density lipoprotein (HDL) cholesterol was measured 
from supernatant after magnesium chloride dextran sulphate precipitation. The 
serum concentration of LDL cholesterol was determined by a direct cholesterol 
measurement (Cat No 981656, Thermo Electron, Vantaa, Finland). 
Serum fatty acids.  Serum fatty acids (arachidonic, linoleic and linolenic adic) were 
extracted from serum with chloroform-methanol (2:1) and water was added. The 
two phases were separated after centrifugation and the upper phase was discarded. 
To the chloroform phase, methanol-water (1:1) was added and the extraction was 
repeated. The chloroform phase was evaporated under nitrogen. For methylation, 
the residue was treated with sulphuric acid-methanol (1:50) at + 85 ºC for 2 h. The 
mixture was extracted with petroleum ether. The fatty acids from the ether phase 
were determined by a model 5890 gas chromatograph (Hewlett Packard, Avondale, 
Pennsylvania, US) equipped with a flame ionization detector and NB-351 capillary 
column (HNU-Nordion, Helsinki, Finland).  
Serum folate and plasma homocysteine. Serum folate concentrations were 
measured by Quantaphase II radioimmunoassay (Bio-Rad, Hercules, California, 
US). The serum total homocysteine concentrations were analyzed by HPLC at the 
National Public Health Institute, Helsinki, Finland (Schwab et al, 2002). 
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5. RESULTS 
 
5.1. Extraction of phenolic antioxidants from sage (I) 
 
In this work, the radical scavenging activity towards DPPH• radical was used to 
evaluate the applicability and efficiency of different methods to extract antioxidants 
from sage. The highest radical scavenging activity (1/IC50 value 25) was attributed 
to the total extract from PHWE without solid phase trapping. Radical scavenging 
activity of the extracts obtained by hydrodistillation and ultrasonication-assisted 
methanol extraction were similar (1/IC50 values 14.3 and 12.0, respectively) and 
slightly weaker than the activity of the extract obtained by maceration with 70% 
ethanol (1/IC50 value 19.3).  
PHWE was tested at three temperatures:  70, 100 and 150 °C. The extraction at 100 
°C yielded the highest radical scavenging activity in the extract. This was despite 
the higher recovery of identified phenolic analytes (rosmarinic acid, carnosol, 
carnosic acid and methyl carnosate) obtained by extraction at 150 °C. The HPLC 
profile of PHWE extract without solid phase trap was similar to the one obtained by 
ultrasonication-assisted methanol extraction. Of the tested solid phase traps, 
cyclohexyl trapping material resulted in consistently higher radical scavenging 
activity as compared to C18 trapping material, despite the fact that rosmarinic acid 
was more strongly attached to C18 trap material.    
The hydrodistillation method with the most polar solvent, water, extracted only the 
polar compounds from sage. The second most polar solvent, 70% ethanol, also 
extracted some of the less polar compounds. Methanol with a less polar nature 
easily extracted less polar compounds. However, among conventional extraction 
techniques the highest antioxidant activity was achieved in the maceration with 
70% ethanol, and also the highest recovery of rosmarinic acid was achieved with 
this solvent.  
As the hydrodistillation method was used to prepare extracts for usage in further 
studies, the mean yields of dry extracts (% weight of the original material) for 
different herbs were: S. officinalis 25%, R. officinalis 24%, T. vulgaris 29%, O. 
vulgare 36% and O. onites 27%. 
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5.2. Phenolic compounds in Lamiaceae extracts (II, III, IV) and study juices (V) 
 
In study II, the amounts of total phenolic compounds determined as GAE in the 
studied extracts were: oregano 149mg/g, rosemary 185mg/g, sage 166mg/g and 
thyme 96mg/g. In this work, no HPLC analyses for the individual phenolic 
compounds were carried out. The total phenolic content of O. onites extract used in 
study III and study IV was determined to be 134mg GAE/g. In the single dose of 
3.75 g oregano extract ingested in study III, the calculated amount of total phenolic 
compounds was about 500 mg GAE. 
To identify as many phenolic constituents of O. onites as possible in study III, 
altogether 45 compounds were included in the list of analytes to be screened. As a 
result, the following phenolic acids were quantified: rosmarinic acid (12.7 mg/g), 
protocatechuic acid (2.1 mg/g), p-coumaric acid (1.0 mg/g), ferulic acid 
(0.50mg/g), chlorogenic acid (0.31mg/g) and gallic acid (0.15mg/g). In total, the 
dose ingested contained 63 mg (223 μmol) of quantified phenolic acids. Also 
luteolin (3.55 mg/g) and eriodictyol (0.19 mg/g) were found in the extract; 
however, they were not included in the list of analytes in urine analyses.  
In study V, O. vulgare extract was used as antioxidant polyphenol supplement. The 
total phenolic content of the study extract, determined as GAE, was 156 mg/g. In 
the HPLC analyses, the same selection of analytes as in study III were used, and the 
following phenolic acids were quantified: rosmarinic acid (16.03 mg/g), 
protocatechuic acid (1.30 mg/g), ferulic acid (0.37 mg/g), gallic acid (0.22 mg/g), 
caffeic acid (0.18 mg/g), chlorogenic acid (0,16 mg/g) and p-coumaric acid (0,06 
mg/g). Of the flavonoids, luteolin (1.99mg/g) and eriodictyol (0.11 mg/g) were 
found. In the publication V, the described phenolic composition of O. vulgare 
extract was incorrect, i.e. the extract was reported to have a phenolic profile 
different from the one reported here. The explanation for this discrepancy is that in 
the published article, analysis results from a different batch of O. vulgare extract 
were erroneously reported. The phenolic composition of O. vulgare extract 
presented above is the correct phenolic content of the supplement used. The 
reported total phenolic contents i.e. 300 mg GAE and 600 mg GAE per day for LP 
and HP juices, respectively, were correct. The correct daily doses of quantified 
phenolic compounds in the study juices were 41 mg in the LP group and 82 mg in 
the HP group, corresponding to 131 μmol and 262 μmol of compounds, 
respectively.   
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In the HPLC analyses of study juices, the following phenolic compounds were 
identified (Table 5.): 
 
Table 5. Identified phenolic acids and flavonoids (mg/L) in study (V) juices. 
LP = low phenolic, HP = high phenolic. 
 
Compound Placebo juice LP juice HP juice 
rosmarinic acid - 74.64 155.9 
protocatechuic acid - 8.03 17.57 
ferulic acid 1.05 7.08 14.65 
caffeic acid - 1.83 3.39 
p-coumaric acid 0.04 6.40 12.45 
luteolin - 23.08 42.63 
eriodictyol - 1.08 1.97 
naringenin 0.31 * * 
hesperetin 1.13 0.75 0.69 
* = identified but not quantified due to partial overlapping of the signal. 
 
5.3. Antioxidant activity of Lamiaceae extracts, their phenolic constituents, 
 human metabolites and study juices in vitro (II, IV, V) 
 
In study II, the in vitro antioxidant activity of four Lamiaceae extracts: oregano, 
rosemary, sage and thyme was studied using five different assays. In Table 6., the 
ranking order of the extracts in these five assays is given. 
 
Table 6. The ranking order of Lamiaceae extracts in study II using five different in 
antioxidant methods. * Sum of rankings = the combined ranking from the five 
assays.  
 
Method Sage Oregano Rosemary Thyme 
Fe3+ to Fe2+ reduction 1 3 2 4 
DPPH• scavenging 2 3 1 4 
ABTS•+ scavenging 1 2 2 3 
Deoxyribose assay (OH•) 1 2 3 3 
LDL oxidation 2 3 1 4 
* Sum of rankings 7 13 9 18 
 68
Based on all the five assays used, sage extract was the one with the highest 
antioxidant activity, closely followed by rosemary extract. Oregano extract 
exhibited antioxidant activity inferior to these two extracts, but clearly superior to 
that of thyme extract. In the iron reductive capacity assay, the reductive power of 
all the extracts was lower as compared to that of ascorbic acid, a strong reductive 
agent used as a standard in this assay. The relative reductive efficiency varied from 
0.099 (thyme) to 0.201 (sage), compared to ascorbic acid having a value of 1.000. 
In the radical scavenging assays, sage showed the strongest antioxidant activity, 
followed by rosemary and oregano. Of the tested samples, thyme exhibited clearly 
the weakest radical scavenging capacity. In ABTS•+ assay, the determined TEAC 
values (mmol/L) were in the range of 4.9-15.5., depending on the sample and the 
time point of determination.  In the LDL oxidation assay, the extracts were capable 
of delaying the onset of LDL oxidation. None of the extracts were capable of 
slowing down the rate of LDL oxidation in the propagation phase, as judged by the 
slopes of oxidation curves. 
In study IV, the antioxidant activity of phenolic acids identified from O. onites as 
well as their urinary human metabolites (from study III) was evaluated using 
DPPH• scavenging and LDL oxidation assays. Based on their radical scavenging 
activity, compounds could be classified into inactive, intermediately active and 
highly active ones. The following compounds were practically inactive against 
DPPH• radical (activity too low for determination of IC50 value): p-hydroxybenzoic 
acid, vanillic acid, m-hydroxyphenylacetic acid, m-hydroxyphenylpropionic acid 
and p-coumaric acid. Intermediate activity was observed for the following 
compounds, in decreasing order of activity: syringic acid > eriodictyol > caffeic 
acid > chlorogenic acid > protocatechuic acid > ferulic acid. The highest radical 
scavenging capacity was observed, in decreasing order of activity, for gallic acid > 
3,4-dihydroxyphenylacetic acid > luteolin = rosmarinic acid > 3,4-
dihydroxyphenylpropionic acid. Based on their molar lag-phase prolonging effect 
in the LDL oxidation assay, compounds were classified into inactive, 
intermediately active and highly active ones. The inactive compounds included 
ferulic acid, syringic acid, vanillic acid, p-coumaric acid, m-hydroxyphenylacetic 
acid, p-hydroxybenzoic acid and m-hydroxyphenylpropionic acid. Gallic acid, 3,4-
dihydroxyphenylpropionic acid and protocatechuic acid had an intermediate 
antioxidant effect in this assay. The following compounds, in decreasing order of 
activity, showed a strong increasing effect on the lag-time: luteolin > eriodictyol > 
rosmarinic acid > caffeic acid > 3,4-dihydroxyphenylacetic acid > chlorogenic acid.  
 69
The juices used in study V were tested for their DPPH• scavenging activities. The 
1/IC50 values for the juices were 16, 491 and 861 for placebo juice, LP juice and 
HP juice, respectively. 
 
5.4. Excretion of urinary phenolic metabolites of O. onites extract in humans (III) 
 
In study III, six volunteers ingested 3.75g of O. onites extract packed in hard 
gelatine capsules and the urinary excretion of phenolic metabolites was followed 
for 48 hours. The dose corresponded to 500 mg GAE of total phenolic compounds 
and 63 mg (223 μmol) of identified phenolic acids. A marked increase was 
observed in the urinary excretion of phenolic metabolites. During 0-24 hours of the 
follow-up time, the excretion was about four-fold (403±69 μmol/d) as compared to 
baseline excretion, 95±11 μmol/d. During 24-48 hours of the follow-up, the 
excretion was about double (172±21 μmol/d) as compared to the baseline. 
At the baseline, the major compound excreted in urine was vanillic acid, followed 
by p-hydroxybenzoic acid, m-hydroxyphenylacetic acid, ferulic acid and 3,4-
dihydroxyphenylacetic acid, respectively. Low amounts of protocatechuic acid, 
syringic acid, p-coumaric acid and caffeic acid were also detected. During the first 
day of the follow-up, the main compound excreted was p-hydroxybenzoic acid, 
followed by, in decreasing order of quantity, vanillic acid, m-hydroxyphenylacetic 
acid, protocatechuic acid, ferulic acid and 3,4-dihydroxyphenylacetic acid. Minor 
amounts of syringic acid, caffeic acid and p-coumaric acid were also detected. 
During the second day, m-hydroxyphenylacetic acid was the main compound 
excreted in urine, followed by, in decreasing order of quantity, vanillic acid, p-
hydroxybenzoic acid, ferulic acid and 3,4-dihydroxyphenylacetic acid. Low 
amounts of protocatechuic acid, caffeic acid, p-coumaric acid and syringic acid 
were also excreted. Rosmarinic acid, gallic acid or chlorogenic acid were not 
detected in any urine samples at the baseline or during the 48-hour follow-up time. 
During the total 48-hour follow-up time, the mean increasing effect of the 
supplement on the excretion of identified phenolic compounds (baseline extraction 
subtracted) was altogether 385±114 μmol. The main metabolite excreted was p-
hydroxybenzoic acid, representing 45% of the identified urinary phenolics. 
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5.5. Effects of O. vulgare extract supplementation on 
 antioxidant biomarkers in vivo (V) 
 
In the O. vulgare extract supplementation study, the compliance of the participants 
was good. None of the participants dropped out during the 4-week study.  No 
adverse effects were reported. No significant changes were detected in serum 
ALAT or γ-GT between study groups during the study period. Serum creatinine 
concentration decreased by 2% (P=0.123) in LP group and increased by 5% 
(P=0.015) in HP group. The significant increase in HP group was mostly due to 
>10 μmol/L increase in three study subjects. In the post hoc analysis, the increase 
of serum creatinine concentration was significantly greater in the HP group as 
compared with LP group (P=0.002), but no significant difference was seen between 
HP and placebo groups (P=0.144). Pearson’s correlation coefficient (R) between 
changes in excretion of total phenolics and changes in serum creatinine was 0.25 
(P=0.107) in the whole study population. In a linear regression model, the variables 
with strongest associations with increase in serum creatinine concentration were 
changes in serum TRAP concentration (standardised coefficient 0.44, P=0.001), 
urinary excretion of vanillic acid (0.36, 0.009), serum lagtime (-0.38, 0.004), 
plasma total homocysteine (0.30, 0.023) and serum γ-GT (0.34, 0.010), adjusted R2 
for model was 0.44, P<0.001.  
At the baseline, the study groups did not differ from each other by physical 
characteristics or age. However, a significant difference was observed in the 
baseline urinary excretion of phenolic compounds (P=0.013): the excretion in the 
placebo and LP group were 26% and 72% higher than in HP group, respectively.  
The consumption of placebo juice or juices enriched with oregano extract did not 
have effects on the concentrations of serum lipoproteins (triglycerides, total-, LDL- 
or HDL cholesterol), or plasma tHcy concentrations. Changes in the 24-hour 
excretion of phenolic compounds were different between the study groups: the 
excretion decreased 10% in the placebo group, while excretion increased 2% in the 
LP and 85% in the HP groups (P < 0.001).   
A favourable effect was seen in plasma TRAP within HP group, as TRAP increased 
significantly in short-term measurements (P=0.017). Conversely, an unfavourable 
effect was noticed in long-term measurement within LP group, as the level of LDL 
baseline conjugated dienes increased (P=0.023). No significant changes between 
the study groups in either short-or long-term measurements of antioxidant capacity 
or lipid peroxidation were found.   
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6. DISCUSSION  
 
6.1. Evaluation of the methods used 
 
6.1.1. Extraction of the herb material 
 
Of the two water-based methods, PHWE exhibited higher extraction efficiency than 
hydrodistillation at similar temperature. The high pressure in PHWE possibly eases 
the penetration of water into the plant matrix or otherwise physically alters the matrix, 
resulting in extraction of also the less polar compounds such as carnosic acid. PHWE 
showed to offer a promising alternative to conventional solid-liquid techniques in the 
extraction from plant matrixes of natural compounds with a variety of polarities. The 
hydrodistillation method was, however, chosen for the production of the study 
extracts due to several reasons. As shown for sage in study I, the hydrodistillation 
method extracted only components of polar nature as compared to the other 
techniques studied; the same finding was confirmed in a recent study of Kivilompolo 
& Hyötyläinen (2007). The more lipophilic constituents of Lamiaceae herbs, for 
example diterpenes, in human extract supplements were avoided. The major reason 
for choosing this technique was that the sensory properties of the produced extracts 
were acceptable, as the characteristic strong aroma and taste of Lamiaceae herbs was 
weakened due to removal of volatile oils during the hydrodistillation. As purified 
water was used as the extraction solvent, risk of organic solvent residues remaining in 
the extracts was avoided. 
The hydrodistillation method was, contrary to pressurised hot water extraction, 
easily transformable to a larger scale production, as was seen in the preparation of 
O. vulgare extract for study V. As can been seen from the yields of dry extracts by 
the hydrodistillation method, a large portion of plant material was extractable with 
boiling water. In a study of Parejo et al (2002), steam distillation (volatile oil 
removing process) was shown to increase the antioxidant capacity, determined as 
radical scavenging capacity, of Lamiaceae herb extracts as compared to non-
distilled extracts. Further support for our choice of extraction technique for the 
preparation of study extract from O. vulgare was presented by Kivilompolo & 
Hyötyläinen (2007), who reported that the rosmarinic acid content of O. vulgare 
extract prepared similarly to our hydrodistillation method yielded a higher recovery 
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of rosmarinic acid from herb material as compared to extraction with 60% ethanol, 
and similar to 80% methanol. 
 
6.1.2. Total phenolic assay and in vitro antioxidant methods 
 
In this work, the rough evalution of the total phenolic content of the study extracts 
was carried out by using the FC reagent. The more accurate analysis of the phenolic 
content was carried out using chromatographic techniques. The FC method has 
been widely used and has many advantages: it is simple, sensitive and precise, and 
if the original procedure is accurately followed, comparable results can be produced 
(Prior et al, 2005). There are, however, problems concerning the use of this 
method: depending on the sample in question, several other constituents than 
phenolic compounds are capable of reducing action and may thus co-react in the 
assay. The most common interfering substances are ascorbic acid, sugars, aromatic 
amines, organic acids and Fe2+ (Prior et al, 2005). When interpreting the results, the 
possible confounding effects of co-reactants have to be kept in mind. Also the use 
of varying modifications of the original procedure of Singleton & Rossi (1965) has 
resulted in problems when comparing results between studies. A properly validated 
version of this assay traditionally used for determination of the total phenolic 
content of the sample has been suggested as an antioxidant method of choice for 
determining the total reductive capacity of samples (Huang et al, 2005). 
The reductive capacity of the extracts was studied using the Fe3+ to Fe2+ reduction 
assay. This method, similarly to FC assay and DPPH• assay is based on the 
determination of the the electron donating ability of the sample, and as they should 
reflect the same type of antioxidant action, it is interesting to compare the results 
from these assays. The major drawback of the Fe3+ to Fe2+ reduction assay is that it 
cannot detect antioxidants acting by hydrogen transfer mediated radical scavenging 
mechanism (Prior et al, 2005). However, the reductive power of a sample still 
reflects the ability to maintain and modulate redox tone in plasma and tissues. As 
the Fe3+ to Fe2+ reduction assay is totally based on the electron transfer process, it 
can, combined with other antioxidant assays, be used to characterize the antioxidant 
properties of a sample in question. 
The DPPH• radical scavenging assay used to study the radical scavenging 
properties of the study extracts and phenolic compounds by electron donation, and 
possibly to a lesser extent by hydrogen atom transfer, was the first antioxidant 
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method set up in our laboratory in Helsinki. The method has often been utilised in 
antioxidant research due to its simplicity, rapidity and minor instrumentation 
requirements (Prior et al, 2005). In contrast to the chemically generated radicals 
such as ABTS•+, DPPH• may be utilized in aqueous and nonpolar organic solvents 
such as benzene and can be used to examine both hydrophilic and lipophilic 
antioxidants. However, it has been hard to compare the DPPH• scavenging capacity 
data between different laboratories or from the same group at different times 
because the results are highly dependent e.g. on the reaction time, the concentration 
of DPPH• used and the antioxidant(s) in the assay mixture. Another drawback is 
that this radical is, as compared to biologically relevant radicals, very long-lived 
and the rating of radical-scavenging activity based on just DPPH• assay may lead to 
misinterpretations. Also, due to molecular structure of DPPH• radical (Figure 2.), 
the radical scavenging action of an antioxidant is largely dependent on its 
molecular size: in case of larger molecules such as flavonoid glycosides, the steric 
hindrance of DPPH• radical affects the capability of antioxidant action (Prior et al, 
2005), and may result in too low activities reported.  
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Figure 2. Structure of the DPPH• radical molecule. 
 
The radical scavenging properties if the study extracts were also studied using 
ABTS•+ radical. Advantages of this TEAC method are its operational simplicity 
and rapidity, usability for both hydrophilic and lipophilic antioxidants as well as 
possibility of automation (Prior et al, 2005). On the other hand, ABTS•+ radical is 
non-physiological, and use of a short time-point detection of absorbance may result 
in low TEAC values. Also variations in the assay conditions pose challenges for 
comparison of results between studies. It has been stated that the use of TEAC 
assay is not ideal to quantitatively evaluate the antioxidant properties of a sample, 
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but it can be used to provide a ranking order of antioxidant samples (Van den Berg 
et al, 1999). 
The antioxidant properties of the study extracts were also studied in the deoxyribose 
oxidative degradation assay. This assay has been designed for testing the capability of 
antioxidants to scavenge OH• radicals generated in reactions between hydrogen 
peroxide and iron ions. The approach of generating and testing a radical with real 
biological relevance is ideal; however, the use of metal ions in radical generation can 
lead to misinterpretations, as metal chelating action cannot be distinguished from 
radical scavenging action (Huang et al, 2005). In the assay modification we used, the 
excess of iron ions was chelated with EDTA. The real relevance of in vitro 
scavenging activity of OH• radicals by a sample has also been criticised: detrimental 
OH• radicals are short-lived and react readily with practically any molecule nearby, 
compared to which dietary antioxidants in human body are present in insignificant 
amounts. Thus, the preventive action against OH• radical formation by metal 
chelation or decomposition of H2O2 into harmless products in vivo by polyphenols is 
more feasible, and the approach of measuring the capacity of food phytochemicals to 
prevent the in vitro formation of OH• radicals instead of measuring the OH• radical 
scavenging capacity has been suggested (Huang et al, 2005).  
As the oxidation of LDL particles has been proposed as one of the major events n 
the aetiology of atherosclerosis, we chose to use the in vitro human LDL oxidation 
assay to characterise the antioxidant properties of our study extracts and some 
phenolic components. In copper-induced LDL oxidation model, lipid peroxidation 
requires continuous formation of radicals at the lipoprotein particle surface by the 
Cu+/Cu2+ redox cycle, in which hydroperoxides and LDL-associated reducing 
agents have an important role. Following the production of free radicals, 
peroxidation propagates via their interactions with PUFA. Even though the 
pathophysiological role of both copper and radical induced oxidation of LDL have 
been questioned, copper catalysed LDL oxidation model may be regarded as a 
reasonable model for oxidation of LDL in vivo, as it plays a catalyzing role and also 
induces production of free radicals when reacting with LDL-associated antioxidants 
or hydroperoxides (Pinchuk & Lichtenberg, 2002). This method is advantageous 
for providing information on the kinetics of oxidation and the spectroscopic 
determination of products of oxidation at 234 nm has little background interference 
(Pinchuk & Lichtenberg, 2002). However, there are some shortcomings: both 
conjugated diene hydroperoxides and 5-ketocholesterol absorb at the same 
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wavelength. As the method requires isolated LDL from different volunteers to be 
prepared on a regular basis, it is not possible to get analogous LDL preparations to 
be used. This limits the use of LDL oxidation assay as a consistent, high-
throughput approach assay method. Pinchuk & Lichtenberg (2002) have stated that 
the key factor governing the lag-time in copper-induced oxidation model is the 
amount of pre-formed ROOH in the sample to be oxidized. Thus, an antioxidant 
may act by enhancing the rate of ROOH decomposition during the lag-phase. In 
addition, several other antioxidant mechanisms, independently or concurrently, can 
be involved: chelation of transition metal ions, inhibition of binding of metal ions 
to apolipoprotein surface, inhibition of inter- or intraparticle transfer of reactive 
intermediates, scavenging of free radicals or reducing of transition metal ions 
(Pinchuk & Lichtenberg, 2002). Due to several possible mechanisms of action, an 
observed increase in the lag-phase by addition of antioxidant cannot be simply 
attributed to a certain antioxidant mechanism. Additional information on the 
mechanisms of action involved might have been found by also using AAPH radical 
induction in the assay. 
In Table 7., evaluation of characteristics of each method is presented. 
 
Table 7. Evaluation of selected characteristics of in vitro antioxidant methods used 
in this study: simplicity of use, instrumentation required, biological relevance, and 
the principal antioxidant mechanism(s) involved in the assay. DPPH• = 1,1-
diphenyl-2-picrylhydrazyl radical, TEAC = Trolox® equivalent antioxidant 
capacity, Fe red. = Fe3+ to Fe2+ reduction assay, OH• = deoxyribose degradation 
assay, FC = Folin-Ciocalteu assay, LDL ox. = copper-induced LDL oxidation 
assay. +, ++, +++ = desirable to highly desired characteristic; -, --, --- = less 
desirable to highly undesirable based on this characteristic. (Partially modified 
from Huang et al, 2005 and Prior et al, 2005).   
 
Method Simplicity Instruments  Clinical  
relevance  
Mechanism 
DPPH• +++ ++ --- single electron transfer 
TEAC + ++ - single electron transfer 
Fe red. +++ ++ -- single electron transfer 
OH• - ++ + hydrogen atom transfer 
FC ++ ++ -- single electron transfer 
LDL ox. - - ++ mixed 
 76
To conclude, this study employed a range of assays to characterise the in vitro 
antioxidant properties of different Lamiaceae extracts as well as phenolic 
constituents and human metabolites of O. onites. The results obtained from 
different assays clearly demonstrate the inadequacy of using a single method to 
evaluate the antioxidant properties of a sample. Both single electron transfer and 
hydrogen atom transfer based radical scavenging assays were used. Assays 
determining the peroxyl radical scavenging activity, such as ORAC or TRAP, 
would have been of greater physiological relevance as compared to DPPH• or 
ABTS•+ scavenging based assays. The TRAP method was, however, employed to 
study the antioxidant capacity of human plasma in study V.  
 
6.1.3. Kinetic study 
 
Subjects and study design 
 
In the kinetic study, which followed the urinary excretion of phenolic metabolites 
of O. onites, data was obtained from six study participants. Although this is a rather 
low number of study subjects, it can still be considered as adequate for this type of 
experiment, especially as the interindividual variation remained reasonable. One 
week prior to and during the experiment, the participants consumed a polyphenol-
restricted diet to avoid confounding effects from the diet. In many kinetic studies, 
the follow-up time has been restricted to few hours after the ingestion of the 
supplement. In our study, the urinary excretion of phenolic metabolites from 
oregano was followed for two days, which allowed us to detect both the rapid 
metabolites and the colonic metabolites with a prolonged elimination time. 
 
HPLC analyses of  O. onites extract and urine 
 
The HPLC-CEAD combination in the analysis of phenolic compounds is sensitive 
and precise, but it has been criticised for the requirement of high expertise from its 
users. The methods used in this study to identify and quantify the separate phenolic 
compounds in the extract and urine samples, have been earlier used for similar 
purposes, and the analyses were carried out by expertised users of the system. 
Some limitations occur in the analysis of metabolites of phenolic compounds when 
using the CEAD detector: compounds without a free hydroxyl group, for example 
hippuric acid, cannot be detected. The analysis of phenolic compounds after acidic 
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or enzymatic hydrolysis simplifies the identification, but at a same time, the 
information is limited to aglycone forms of compounds. The presence of 45 
phenolic compounds was screened in the oregano extract, and based on these 
analyses, the urine samples were screened for a selection of 13 phenolic 
compounds. Even though a large number of standards were used, the 
characterisation of the phenolic composition of hydrodistilled extract of O. onites 
remained partial. This is a general problem when using supplements of natural 
origin; the variety of compounds is huge, and as all the potential parent compounds 
are not identified, complete conclusion on the origins of metabolites cannot be 
drawn. On the other hand, the other approach in bioavailability studies is to use a 
supplement consisting of a single compound. In this case, the parent compound and 
thus the origin of metabolites is known, but the biological relevance of such a 
supplement remains negligible. 
 
6.1.4. Supplementation study 
 
Subjects, study design and supplement used 
 
In the oregano supplementation study, a randomised, double-blinded, placebo-
controlled study design was used. The recruited subjects were randomised into 
three groups, one group received placebo juice, one group received LP juice and 
one group HP juice, and neither the study subjects nor the research personnel were 
aware of their type of supplement before the analysis of the results. By the use of 
placebo juice, the possible effects of the juice base were controlled. The effects of 
supplementation on the antioxidant parameters were determined both short-term 
(1.5 hours after ingestion of 250 mL of the study juices) and long-term (after 4 
weeks of regular juice consumption, 3x125 mL of study juices every day). One 
week prior to and during the experiment, the participants consumed a polyphenol-
restricted diet, and a four-day food recording was collected from all the study 
participants at the baseline and in the end of the study. The participants were also 
advised to report any skipping of juice doses. The purpose of these steps was to 
diminish the effects of confounding dietary factors and to check the compliance 
towards given instructions. 
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All the recruited men were healthy non-smokers, and most probably had a normal, 
balanced redox status in their body. Thus, a question remained, whether 
participants with elevated oxidative stress, for example smokers, might have had a 
different response on the oregano antioxidant supplementation.  
 
Assessment of antioxidant capacity and lipid peroxidation 
  
Several methods were used to assess the antioxidant capacity and lipid peroxidation 
from blood samples obtained: plasma TRAP, resistance of serum lipids to copper-
induced oxidation, levels of baseline (without induced oxidation) conjugated dienes 
in LDL, and the concentration of plasma F2-isoprostanes. TRAP was used to 
measure the capacity of a sample to scavenge peroxyl radicals, which are 
physiologically relevant reactive species formed in the process on lipid 
peroxidation in vivo. Often, TRAP is the antioxidant parameter on which 
supplementation with polyphenols has been reported to have an increasing effect. It 
detects all antioxidants capable of chain breaking antioxidant action and is not 
interfered by enzymatic antioxidants present in human samples (Huang et al, 2005). 
However, the assay is relatively complex and time-consuming, and requires high 
expertise and routine from its users. 
The copper-induced oxidation of serum lipids measures the capacity of serum to 
resist the oxidative stress, whereas the baseline LDL conjugated dienes assay 
reflects the in vivo oxidation status of LDL particles. Both of these methods can be 
considered to have a reasonable clinical relevance. 
The in vivo biomarker of lipid peroxidation considered as the most reliable and of 
the highest clinical value are the F2-isoprostanes, highly specific products of 
nonenzymatic peroxidation of arachidonic acid (Roberts & Morrow, 1997; 
Halliwell, 1999; Basu, 2004; Kadiiska et al, 2005; Milne et al, 2007; Montuschi et 
al, 2007). The GC-MS method for determining F2-isoprostanes from human 
samples is laborious and thus costly. The analysis requires expertise, and their use 
is still rather limited as compared to many other in vivo biomarkers of lipid 
peroxidation. 
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6.2. Evaluation of the results 
 
6.2.1. In vitro antioxidant activity and phenolic content of Lamiaceae herb 
 extracts 
 
In study I, all the tested sage extracts exhibited varying degrees of radical 
scavenging activity, the efficacy not being straightly correlated with the rosmarinic 
acid content of extract in question. When the two solid-phase traps were used in the 
PHWE procedure, higher radical scavenging activity was addressed to extract 
obtained by using cyclohexyl trapping material. As the retention of rosmarinic 
acids to cyclohexyl phase is far less than to C18 phase, this observation suggests 
that the radical scavenging properties of PHWE extracts were strongly contributed 
by phenolic compounds other than rosmarinic acid, for example diterpenes present 
in the extract. The phenolic profile of total PHWE extract was very similar to that 
of methanol extract, suggesting that the solvent properties of water in PHWE 
resembled those of methanol. In methanolic sage extract, diterpenes were present in 
higher amount as compared to 70% ethanol extract and hydrodistillation extract. In 
hydrodistillation extract, no traces of diterpenes were found, but instead, more 
compounds of very polar nature were present in the extract. Of the traditional 
extraction techniques, maceration with 70% ethanol yielded the highest radical 
scavenging activity, together with highest concentration of rosmarinic acid. In this 
extract, some diterpenes were also found. Hydrodistilled extract exhibited radical 
scavenging activity slightly higher than the methanolic extract, even though the 
rosmarinic acid content in these extracts was similar, and the methanolic extract 
also contained some amounts of diterpene compounds. This suggests that the highly 
polar constituents of sage, only extracted by the hydrodistillation method, had a 
contribution to the observed radical scavenging action. 
In study II, the total phenolic contents of aqueous Lamiaceae extracts varied from 99 
mg GAE/g for thyme to 185 mg GAE/g for rosemary. For example, the total phenolic 
content of O. vulgare extract obtained by a hydrodistillation procedure was close to 
that of O. vulgare extract obtained by subcritical hot water extraction at 100˚C, 
168mg GAE/g (Rodríguez-Meizoso et al, 2006). All the four aqueous Lamiaceae 
extracts showed to be antioxidative in all our assays used. As the total phenolic assay 
is based on the determination of reductive capacity, i.e. electron transfer capacity, of a 
sample, it is not a surprise that the total phenolic contents of samples were well 
correlated with the results of Fe3+ to Fe2+ reduction assay and DPPH• radical assay: 
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rosemary and sage extracts with the highest total phenolic content showed the highest 
activity in these assays, followed by oregano. Thyme extract, with the lowest total 
phenolic content, exhibited the weakest activity in all four assays. In the methods 
assessing ABTS•+ or OH• radical scavenging capacity, the total phenolic content of 
the samples was not as well correlated with the antioxidant power. For example, in 
the deoxyribose assay i.e. the OH• radical scavenging assay, rosemary and thyme 
exhibited similar activity inferior to sage and oregano. In the LDL oxidation model, 
the order of antioxidant activity was in accordance with the total phenolic contents. 
The antioxidant mechanisms involved cannot be fully elucidated, as all types of 
antioxidant action in this assay result in an increased lag-time, and in polyphenol 
mixtures, like these extracts, several mechanisms of action are involved. However, as 
the rate of oxidation in the propagation phase was not affected, the mechanism(s) 
involved probably is not the chelation of copper ions, but rather the enhancing of the 
non-radical decomposition of ROOH, or scavenging or stabilisation of free radicals 
(Pinchuk & Lichtenberg, 2002).   
 
6.2.2. In vitro antioxidant activity of phenolic constituents in O. onites extract 
 and their urinary metabolites 
 
The structure-activity relationship of the tested phenolic compounds in DPPH• 
radical scavenging assay and copper-induced LDL oxidation assay was not similar; 
however, mono-hydroxylated compounds exhibited antioxidant activity in neither 
assay. This is in agreement with earlier observations. Especially in the case of 
benzoic acid derivatives, an explanation for this could be the carboxylic acid 
moiety, which is electron withdrawing and hampers the hydrogen donation ability 
from aromatic hydroxyl group (Soobrattee et al, 2005). The most active compounds 
in both assays possessed an ortho-dihydroxyl moiety in their structure, suggesting 
this structural feature to have a key role in effective antioxidant action. Ortho-
dihydroxylated phenolic compounds are capable of antioxidant action by several 
mechanisms, for example by chelating Cu2+ions and scavenging free radicals 
(Nardini et al, 1995; Natella et al, 1999). An exception to this was gallic acid, 
trihydroxybenzoic acid, which was the most active against DPPH• radical. This 
superior radical scavenging activity of trihydroxylated phenolics compared to 
corresponding dihydroxylated compounds has been reported e.g. by Siquet et al, 
2006. In the LDL oxidation model, the antioxidant activity of gallic acid was 
weaker than that of protocatechuic acid, which has been explained by Siguet et al 
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(2006) by the higher hydrophilicity as compared to corresponding dihydroxyl 
derivative. 
Most of the urinary metabolites were low in antioxidant activity, but the ortho-
dihydroxylated metabolites still possessed antioxidant capacity. Of these 
metabolites, 3,4-dihydroxyphenylacetic acid showed higher activity in both assays 
as compared to the corresponding propionic acid derivative. The ethanoic side 
chain length seems thus favourable as compared to propionic side chain length, 
which is in agreement with work of Siquet et al, 2006.  
Taking the concentrations of different compounds in the extract into consideration, 
the major role in the antioxidant activity of O. onites extract can be attributed to 
rosmarinic acid, followed by luteolin and protocatechuic acid. Similar findings 
have been reported e.g. for O. vulgare extracts by Exarchou et al (2002). Even 
though some of the urinary metabolites exhibited high antioxidant activity in the in 
vitro assays used, they mainly occur as conjugates in the urine, which usually 
decreases their antioxidant potential in vivo. 
 
6.2.3. Bioavailability and metabolism of O. onites extract in humans 
 
The phenolic compounds from O. onites were shown to be at least partially 
absorbed, metabolised and excreted in urine in study III. The study subjects 
consumed a phenolic-restricted diet prior to and during the study, which minimised 
the role of diet as a source of phenolic metabolites. Low concentration of the main 
metabolite, p-hydroxybenzoic acid, was present in 24-hour baseline urine, but after 
ingestion of the extract, the excretion multiplied. The maximum urinary 
concentration of this compound was observed in urine within 4 hours from the 
ingestion of the extract, which indicates that the parent compound(s) was rapidly 
absorbed, metabolised and excreted in urine. p-Hydroxybenzoic acid has not been 
described as a human metabolite of polyphenol metabolism, although low amounts 
have been reported e.g. as in vitro fermentation products of quercitrin with human 
intestinal microflora (Kim et al, 1999) and as a metabolite of anthocyanin 
pelargonidin in rat urine (El Mohsen et al, 2006). Hydroxyphenylpropionic acids 
are metabolites of the colonic degradation of hydroxycinnamates as well as 
flavonoids (Rechner et al, 2002a), and p-hydroxybenzoic acid was suggested to be 
a potential metabolite from the human colonic metabolism of these compounds. In 
most studies, p-hydroxybenzoic acid has not been on the list of included analytes, 
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possibly because metabolism of aromatic acids in diet also produces p-
hydroxybenzoic acid. Even though low amounts of p-hydroxybenzoic acid has been 
found in extracts of Lamiaceae herbs, in O. onites extract used in this study, no 
traces of it were detected. 
In one of the few human studies on Lamiaceae herbs, rosmarinic acid from Perilla 
extract reached it maximum plasma concentration at 30 minutes after ingestion of 
the extract (Baba et al, 2005). This suggests that rosmarinic acid was, at least 
partially, absorbed from the stomach. If the rosmarinic acid in O. onites extract was 
absorbed in the stomach or in the upper part of the small intestine, it could have 
acted as a parent compound for p-hydroxybenzoic acid. Due to the partial 
characterisation of the study extract, the origin of the metabolites cannot be 
quantitatively elucidated. However, the total amount of oregano extract derived 
phenolic metabolites detected in the urine exceeded the amount of identified 
phenolic components in the extract.   
Due to the 48-hour follow-up time, we also detected the excretion of colonic 
metabolites of the extract, the phenylacetic acids. In further analyses, we identified 
propionic acid derivatives from the colonic metabolism in the urine samples, and 
although they were not quantified, they further increased the amount of excreted 
urinary phenolic metabolites. 
 
6.2.4. Effects of O. vulgare extract supplementation on antioxidant biomarkers in vivo 
 
The lack of short- or long-time effects of oregano supplementation on parameters 
reflecting antioxidant status or lipid peroxidation was despite the use of several 
biomarkers with clinical relevance in vivo. O. vulgare extract exhibited antioxidant 
potential in different in vitro assays, and as it had a comparable content of 
identified phenolic compounds to that of O. onites extract used in study III, we 
were expecting to see some antioxidant effects in vivo. The lack of effects 
reawakened the questions that were also considered when designing the study 
setting: were the type or dose of phenolic compounds administered right? Were 
oregano polyphenols weakly absorbed or metabolically inactivated so rapidly that 
concentrations of polyphenols present in vivo were not high enough to have a role 
in antioxidant defence? Was the choice of recruiting healthy, nonsmoking study 
participants correct, or would the results have been different in subjects with an 
elevated level of oxidative stress due to some disease or exogenic exposing factor 
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such as tobacco smoking? Could some other biomarkers of lipid peroxidation or 
antioxidant status have shown effects? 
During the past two decades, the research on polyphenols has mainly been targeted 
at their antioxidant properties. Today, accumulating data from a variety of 
polyphenol studies and the inconsistent findings on the antioxidant action of 
polyphenols in human body suggest that the classical direct antioxidant action is a 
simplistic way to conceive the bioactivity of polyphenols in humans (Noguchi, 
2002; Williams et al, 2004). The concentrations of polyphenols or their metabolites 
in the human body may be inadequate as compared to other antioxidants to have 
any detectable effects on antioxidant status or lipid peroxidation, but the biological 
effects of polyphenols could be mediated via cell signalling, in which lower in vivo 
concentrations are needed. For example, oxidised LDL induces a number of genes 
that have a role in the initiation and progression of atherosclerosis. These genes 
regulating cell growth, survival, adhesion and inflammatory responses are up-
regulated via nuclear receptor-dependent pathways by ox-LDL. The health-
beneficial actions, protection of the cardiovascular and neurological system and 
prevention of cancer, may be mediated via modulatory actions of polyphenols on 
the regulation of gene expression involved in protein degradation and 
transcriptional pathways (Noguchi, 2002; Williams et al, 2004). In addition to the 
observed antioxidant action in vitro, polyphenols have been shown to have a huge 
variety of biological activities (reviewed by Halliwell, 2007): they are capable of 
inhibiting telomerase, glutamate dehydrogenase, cyclooxygenase, lipoxygenase, 
xanthine oxidase, matrix metalloproteinases, angiotensin-converting enzyme, 
proteasome, cytochrome p-450 and sulphotransferase enzyme activities, affecting 
signal transduction pathways and interacting with sirtuins, histone deacetylase 
enzymes with a role in the ageing process. They may also have interactions with 
cellular drug transport systems or glucose transmembrane transport, affect cell 
cycle regulation, protein glycation, modulate paraoxonase, myeloperoxidase and 
thyroid peroxidase activity, increase endothelial nitric oxide production and affect 
the platelet function. All of these effects have been shown in vitro, and it is still 
uncertain whether these potential modulatory actions have a role in human body. 
However, this diversity of potential mechanisms of health-beneficial actions 
suggest that the lack of effects in parameters reflecting direct antioxidant action 
does not equal lack of beneficial effects in vivo. 
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7. SUMMARY AND CONCLUSIONS 
 
 
These studies represent a progression starting from studying of extraction 
techniques for Lamiaceae polyphenols, proceeding to in vitro antioxidant studies of 
these extracts and their phenolic constituents, and ending up in elucidating their 
actions in humans. Even though Lamiaceae extracts and their phenolic constituents 
were effective antioxidants in different in vitro models, and phenolic components 
of oregano were absorbed in humans, no antioxidant effects were seen in humans 
after oregano polyphenol supplementation. The promising antioxidant results of 
polyphenols from in vitro studies are thus not enough to predict their action in 
human body. In humans, issues of absorption, metabolism, distribution and 
concentrations in the blood and tissues are of crucial importance for effects of any 
substance. The fact that polyphenol concentrations in blood and tissues are rather 
low even after supplementation with polyphenols suggests that they may not be 
present at a concentration adequate to contribute to body’s antioxidant defence at 
least at a detectable level. 
Even though the most popular hypothesis behind the epidemiologically observed 
protection of polyphenol rich diets against CVD has been related to their 
antioxidant action, also other mechanisms than direct antioxidant activity may be 
involved. This might at least partially explain the lack of consistent evidence on the 
effects of clinical polyphenol supplementations. Diets rich in fruits, vegetables, 
berries and plant based beverages also contain a number of other phytochemicals 
that might contribute to the observed protection, including fiber, 
immunostimulatory agents, inducers of various enzymes such as oxygenases, 
vitamins, potassium, and folate, which could be independently or concurrently 
responsible for the apparent reduction in CVD risk. The low dietary glycemic load 
and energy density of diets rich in plant-derived foods and drinks may also play a 
significant role. It is also possible that high intake of these nutritional factors is 
linked to a generally healthy lifestyle, which comprises various health beneficial 
choices: non-smoking, regular physical activity, and diet in accordance with the 
dietary recommendations. 
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Today, there is a vogue for functional foods and nutritional supplements of natural 
origin, and their market is expanding worldwide. This work illustrates the 
problemacy of studying and interpreting the properties of a potential health-
beneficial ingredient. Most of the antioxidant products on the market lack studies 
on their effects in humans, and they are referred to as antioxidants based on 
literature or in the most advanced case, based on incidental in vitro studies lacking 
reliable standardisation. Furthermore, no kinetic data of these substances in humans 
are available, and thus the extent of absorption, for example, remains unknown. 
The evidence of an ingredient or a mixture of ingredients exhibiting antioxidant 
activity in vitro is far from proven effects in humans. Until the situation changes so 
that the effects need to be substantiated scientifically in well-controlled intervention 
studies with human volunteers, my opinion is that the best dietary way to maintain 
a healthy redox balance is to consume a balanced diet rich in fruits, berries, herbs 
and vegetables, as well as beverages rich in phenolic compounds. This kind of diet, 
as a part of a whole healthy lifestyle, is most probably beneficial for maintaining a 
good cardiovascular health.  
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